UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934
(Amendment No.      )

Filed by the Registrant  ☒

Filed by a Party other than the Registrant

Filed by the Registrant ☒
Filed by a Party other than the Registrant o

Check the appropriate box:

 ☐
o
Preliminary Proxy Statement
 ☐
o
Confidential, for useUse of the Commission onlyOnly (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
 ☐
o
Definitive Additional Materials
 ☐
o
Soliciting Material under Rule 14a-12Pursuant to §240.14a-12

METHODE ELECTRONICS, INC.


(Exact Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other thanOther Than the Registrant)

Payment of Filing Fee (Check the appropriate box):

No fee required.

Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

(1)
o
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
(1)
Title of each class of securities to which transaction applies:

(2)
(2)
Aggregate number of securities to which transaction applies:

(3)
(3)
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

(4)
(4)
Proposed maximum aggregate value of transaction:

(5)
(5)
Total fee paid:

Fee paid previously with preliminary materials.

Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

(1)
o
Fee paid previously with preliminary materials.
o
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
(1)
Amount Previously Paid:

(2)
(2)
Form, Schedule or Registration Statement No.:
(3)
Filing Party:
(4)
Date Filed:

(3)Filing Party:

(4)Date Filed:

   

METHODE ELECTRONICS, INC.

7401
8750 West WilsonBryn Mawr Avenue,

Suite 1000
Chicago, Illinois 60706

60631
(708) 867-6777

NOTICE OF ANNUAL MEETING OF SHAREHOLDERS



TO BE HELD ON SEPTEMBER 14, 201712, 2019

______________________

To the Shareholders of Methode Electronics, Inc.:

Notice is hereby given that the annual meeting of shareholders of Methode Electronics, Inc. will be held on Thursday, September 14, 201712, 2019 at 11:00 a.m., Central Daylight Time, at Methode’s corporate offices at 74017447 West Wilson Avenue, Chicago, Illinois, 60706 for the following purposes:

1.To elect a Board of Directors;
2.To ratify the Audit Committee’s selection of Ernst & Young LLP to serve as our independent registered public accounting firm for the fiscal year ending April 28, 2018;May 2, 2020;
3.To provide advisory approval of Methode’s named executive officer compensation; and
4.To cast an advisory vote on the frequency of future advisory votes on Methode’s named executive officer compensation; and
5.To transact such other business as may properly come before the annual meeting or any adjournment or postponement thereof.

The Board of Directors recommends that you vote “FOR” each of Methode’s nominees for director, “FOR”“FOR” the ratification of Ernst & Young LLP as our independent registered public accounting firm “FOR”and “FOR” advisory approval of Methode’s named executive officer compensation and in favor of a “ONE-YEAR” frequency for the advisory vote on executive compensation.

Our Board of Directors has fixed the close of business on July 17, 201718, 2019 as the record date for the determination of shareholders entitled to notice of and to vote at the annual meeting and at any adjournment or postponement thereof.

We are furnishing materials for our annual meeting on the Internet. You may vote your shares in person by attending our annual meeting, or by proxy. To vote by proxy, you may vote using the Internet, by toll-free telephone number or, if you request and receive a paper copy of the proxy card by mail, by signing, dating and mailing the proxy card in the self-addressed, postage-paid envelope provided.Information regarding voting by using the Internet or by telephone is contained in the Notice of Internet Availability of Proxy Materials. Instructions regarding voting by mail are contained on the proxy card.

It is important that your shares be represented and voted at the annual meeting. Whether or not you plan to attend the annual meeting, please vote on the matters to be considered. Thank you for your interest and cooperation.

By Order of the Board of Directors,

Walter J. Aspatore


Chairman

By Order of the Board of Directors,
Walter J. Aspatore
Chairman

Chicago, Illinois

August 1, 2017


July 26, 2019

METHODE ELECTRONICS, INC.

7401
8750 West WilsonBryn Mawr Avenue,

Suite 1000
Chicago, Illinois 60706

60631
(708) 867-6777



PROXY STATEMENT



ANNUAL MEETING OF SHAREHOLDERS
September 14, 2017

12, 2019

GENERAL INFORMATION

We are furnishing this proxy statement to you in connection with the solicitation of proxies on behalf of Methode Electronics, Inc. (“Methode” or the “Company”) for use at our annual meeting of shareholders to be held on Thursday, September 14, 201712, 2019 at 11:00 a.m., Central Daylight Time, at Methode’s corporate offices at 74017447 West Wilson Avenue, Chicago, Illinois, 60706 and at any adjournment or postponement of the annual meeting. On August 1, 2017,July 26, 2019, we mailed our Notice of Internet Availability of Proxy Materials, which contains instructions for our shareholders to access our proxy statement and annual report over the Internet or request a paper copy of the proxy materials.

At the annual meeting, we will ask our shareholders to (i) elect our Board of Directors, (ii) ratify the Audit Committee’s selection of Ernst & Young LLP (“Ernst & Young”EY”) to serve as our independent registered public accounting firm for fiscal 2018,2020, (iii) provide advisory approval of Methode’s named executive officer compensation, (iv) cast an advisory vote on the frequency of future advisory votes on Methode’s named executive officer compensation, and (v)(iv) consider and vote upon any other business which properly comes before the annual meeting.

The Board of Directors recommends that you vote “FOR” each of Methode’s nominees for director, “FOR”“FOR” the ratification of Ernst & YoungEY as our independent registered public accounting firm and “FOR” advisory approval of Methode’s named executive officer compensation and in favor of a “ONE-YEAR” frequency for the advisory vote on executive compensation.

You may vote your shares in person, by attending our annual meeting, or by proxy. To vote by proxy, you may vote using the Internet, by toll-free telephone number or, if you request and receive a paper copy of the proxy card by mail, by signing, dating and mailing the proxy card in the self-addressed, postage-paid envelope provided.Information regarding voting by using the Internet or by telephone is contained in the Notice of Internet Availability of Proxy Materials. Instructions regarding voting by mail are contained on the proxy card. Please do not submit a proxy card if you have voted by telephone or the Internet.

It is important that your shares be represented and voted at the annual meeting. Whether or not you plan to attend the annual meeting in person, please vote on the matters to be considered.

Record Date; Shares Outstanding

Our Board of Directors has fixed the close of business on July 17, 201718, 2019 as the record date for the determination of shareholders entitled to notice of and to vote at the annual meeting and at any adjournment or postponement thereof. As of the record date, there were 36,810,85337,061,487 shares of our common stock outstanding and entitled to vote at the annual meeting.

Quorum; Votes Required

In deciding all questions, assuming a quorum is present, a holder of Methode’s common stock is entitled to one vote, in person or by proxy, for each share held in such holder’s name on the record date. The presence, in person or by proxy, of the holders of a majority of the outstanding shares of Methode’s common stock is necessary to constitute a quorum at the annual meeting. Both abstentions and broker non-votes are counted as present for the purpose of determining the presence of a quorum at the annual meeting. Generally, broker non-votes occur when shares held by a broker for a beneficial owner are not voted with respect to a particular proposal because the broker lacks discretionary power to vote such shares.

With respect to the election of directors, the ratification of the selection of Ernst & YoungEY as our independent registered public accounting firm and providing advisory approval of our executive compensation, shareholders may vote (1) “for,” (2) “against,” or (3) to “abstain” from voting on each matter and each such matter requires approval by a majority of the shares of common stock represented at the meeting and entitled to vote. On the proposal regarding an advisory vote on the frequency of future advisory votes on executive compensation, shareholders may vote to hold such votes (A) each year, (B) every two years, (C) every three years, or (D) may abstain from voting. On this proposal, the frequency option that receives the affirmative vote of a majority of the shares of common stock represented at the meeting and entitled to vote will be deemed to be approved by the shareholders. If none of the options for this proposal receives a majority vote, we will consider the alternative that receives the highest number of votes cast by the shareholders to be the frequency that has been selected by the shareholders. Both abstentions and broker non-votes will be considered as present but will not be considered as votes in favor of any matter. Broker non-votes

1

are excluded from the “for,” “against” and “abstain” counts, and instead are reported as simply “broker non-votes.” Consequently, abstentions have the effect of voting against these matters, while broker non-votes have no effect as to voting for or against any such matter.

Under New York Stock Exchange rules, the proposal to ratify the selection of Ernst & YoungEY is considered a routine item. Therefore, brokers may vote in their discretion on this matter on behalf of clients who have not furnished voting instructions to the broker. In contrast, all other proposals set forth in this proxy statement are considered non-routine items, and brokers who have not received voting instructions from their clients may not vote on these proposals.

All properly executed and timely delivered proxies will be voted in accordance with the instructions provided. Unless contrary instructions are indicated, proxies will be voted “FOR” each of Methode’s nominees for director, “FOR” the ratification of the selection of Ernst & Young,EY and “FOR” advisory approval of Methode’s named executive officer compensation and in favor of a “ONE-YEAR” frequency for the advisory vote on executive compensation. The Board of Directors knows of no other business that will be presented for consideration at the annual meeting. If any other matter is properly presented, it is the intention of the persons named in the proxy to vote in accordance with their best judgment.

Voting Procedures

It is important that your shares be represented at the annual meeting. You may vote your shares in person, by attending our annual meeting, or by proxy. To vote by proxy, you may vote using the Internet, by toll-free telephone number or, if you request and receive a paper copy of the proxy card by mail, by signing, dating and mailing the proxy card in the self-addressed, postage-paid envelope provided. Information regarding voting by using the Internet or by telephone is contained in the Notice of Internet Availability of Proxy Materials. Instructions regarding voting by mail are contained on the proxy card. Please do not submit a proxy card if you have voted by telephone or the Internet. You may revoke your proxy as described below.

Revoking Your Proxy

If you decide to change your vote, you may revoke your proxy at any time before the annual meeting. You may revoke your proxy by notifying our Corporate Secretary in writing that you wish to revoke your proxy at the following address: Methode Electronics, Inc., 74018750 West WilsonBryn Mawr Avenue, Suite 1000, Chicago, Illinois 60706,60631, attention: Corporate Secretary. You may also revoke your proxy by submitting a later-dated and properly executed proxy (including by means of the telephone or Internet) or by voting in person at the annual meeting. Attendance at the annual meeting will not, by itself, revoke a proxy.

Proxy Solicitation Expenses

The proxy is being solicited on behalf of Methode. We will bear the entire cost of this solicitation. Our directors, officers or other regular employees may solicit proxies by telephone, by e-mail by fax or in person. No additional compensation will be paid to directors, officers and other regular employees for such services. We have retained the services of Innisfree M&A Incorporated (“Innisfree”) to serve as our proxy solicitor in connection with the annual meeting. Innisfree may assist us in soliciting proxies by telephone, email and by other means, and we expect to pay Innisfree a fee of $20,000, plus reasonable expenses.

In the event that beneficial owners of our shares request paperWe will authorize brokers, dealers, banks, voting trustees and other nominees and fiduciaries to forward copies of ourthe proxy materials banks, brokerage houses, fiduciaries and custodians holding shares of our common stock beneficially owned by others as of the record date will be requested to forward such proxy soliciting material to the beneficial owners of such shares andMethode common stock. Upon request, we will be reimbursed by Methodereimburse them for their reasonable out-of-pocket expenses.

Householding of Annual Meeting Materials

We are sending only one copy of our Notice of Internet Availability of Proxy Materials and, if applicable, our proxy materials, to shareholders who share the same last name and address, unless they have notified us that they want to continue receiving multiple copies. This practice, known as “householding,” is designed to reduce duplicate mailings and save printing and postage costs. Shareholders who participate in householding will continue to be able to access and receive separate proxy cards. If you received a householded mailing this year and you would like to have additional copies of our Notice of Internet Availability of Proxy Materials and, if applicable, our proxy materials, mailed to you; if you received multiple copies of our Notice of Internet Availability of Proxy Materials and would prefer to participate in householding; or if you would like to opt out of householding for future mailings, you may do so at any time by contacting us at: Methode Electronics, Inc., 74018750 West WilsonBryn Mawr Avenue, Suite 1000, Chicago, Illinois 60706,60631, Attention: Corporate Secretary, or telephonically at 708-867-6777.

2

CORPORATE GOVERNANCE

We are committed to maintaining high standards of corporate governance in order to serve the long-term interests of Methode and our shareholders.

Director Independence

Our Board of Directors has considered the independence of the nominees for director under the applicable standards of the U.S. Securities and Exchange Commission (“SEC”) and the New York Stock Exchange. Our Board has determined that all of the nominees for director are independent under the applicable standards, except for Donald Duda, our President and Chief Executive Officer. Mr. Duda’s lack of independence relates solely to his service as an executive officer and is not due to any other transactions or relationships.

In addition, our Board of Directors has determined that each member of our Audit Committee, our Compensation Committee and our Nominating and Governance Committee satisfies the independence requirements of the applicable standards, if any, of the SEC and the New York Stock Exchange.

Board Committees

The following chart sets forth the committees of our Board for fiscal 2017.current Committee membership.

Committee

Members

Principal Functions

Number of
Meetings in
Fiscal 2017
2019
Audit

Isabelle C. Goossen (Chair)


Walter J. Aspatore
Stephen F. Gates

Paul G. Shelton


Lawrence B. Skatoff

Oversees accounting and financial reporting and audits of financial statements.

10

Monitors performance of internal audit function and our system of internal control.

Monitors performance, qualifications and independence of our independent registered public accounting firm and makes decisions regarding retention, termination and compensation of the independent registered public accounting firm and approves services provided by the independent registered public accounting firm.

Monitors compliance with legal and regulatory requirements pertaining to financial statements.

Reviews our financial press releases and certain SEC filings.

Discusses with management major financial risk exposures and the steps taken to monitor and control such exposures, and discussdiscusses guidelines and policies by which risk assessment and risk management is undertaken.

If applicable, reviews related party transactions and potential conflict of interest situations.

3

Committee
9
Members
Principal Functions
Number of
Meetings in
Fiscal 2019
Compensation

Stephen F. Gates

Martha Goldberg Aronson (Chair)

Warren L. Batts


Brian J. Cadwallader
Darren M. Dawson

Martha Goldberg Aronson

Isabelle C. Goossen


Christopher J. Hornung
Paul G. Shelton

Oversees our executive compensation policies and plans.

6

Approves goals and incentives for the compensation of our Chief Executive Officer and, with the advice of the Chief Executive Officer, the other executive officers.

Approves grants under our stock and bonus plans.

plan.

Makes decisions regarding the retention, compensation and termination of any Committee compensation consultants,consultant, and monitors their independence.

Evaluates whether risks arising from our compensation policies and practices are reasonably likely to have a material adverse effect.

5

Nominating and


Governance

Christopher J. Hornung (Chair)

Walter J. Aspatore

Warren L. Batts

Stephen F. Gates

(Chair)
Brian J. Cadwallader
Darren M. Dawson
Isabelle C. Goossen
Lawrence B. Skatoff

Recommends director candidates for election to our Board at the annual meeting or to fill vacancies.

4

Recommends Board committee assignments.

Recommends compensation and benefits for directors.

Reviews and recommends revisions to our Corporate Governance Guidelines.

Conducts an annual assessment of Board and committee performance.

performance

Reviews our risk management policies and practices.

Reviews succession planning for our Chief Executive Officer.

5
executive officers.

Committee

Members

Principal Functions

Number of Meetings in Fiscal 2017
Technology

Darren M. Dawson (Chair)


Martha Goldberg Aronson
Walter J. Aspatore

Warren L. Batts

Martha Goldberg Aronson


Christopher J. Hornung

Reviews with management our technology assets and future needs.

4

Reviews technology research and development activities and possible acquisitions of technology.

4

Mr. Gates passed away in July, 2017. Subsequently, the size of the Board was reduced from ten directors to nine directors and Ms. Goldberg Aronson was appointed Chair of our Compensation Committee. The Board expressed its great appreciation for all of the contributions Mr. Gates made over the years.

If applicable, our Audit Committee reviews related party transactions and potential conflict of interest situations in accordance with the Audit Committee Charter and our Code of Business Conduct. We do not have a separate written policy regarding related party transactions and potential conflict of interest situations. Our Code of Business Conduct states that conflicts of interest are prohibited, except as approved by our Board of Directors. In reviewing any such transaction, our Audit Committee and Board of Directors would consider Methode’s rationale for entering into the transaction, alternatives to the transaction, whether the transaction is on terms at least as fair to Methode as would be the case were the transaction entered into with a third party and other relevant factors.

4

During the 20172019 fiscal year, our Board of Directors held twelvefourteen meetings, and no director attended less than 75% of the aggregate of the total number of meetings of our Board and the total number of meetings held by the respective committees on which he or she served. Under our Corporate Governance Guidelines, our directors are expected to attend Board and shareholder meetings and meetings of committees on which they serve. Our directors are expected to meet as frequently as necessary to properly discharge their responsibilities.

Our independent directors hold regularly scheduled executive sessions at which only independent directors are present. Pursuant to our Corporate Governance Guidelines, our Chairman of the Board is the Presiding Director of such sessions.

Our Audit, Compensation, Nominating and Governance and Technology Committees operate pursuant to charters adopted by the Board, which are available on our website atwww.methode.com or in print upon any shareholder’s request. Our Corporate Governance Guidelines are also available on our website atwww.methode.com or in print upon any shareholder’s request.

Board Leadership Structure, Evaluations, Risk Oversight and Compensation Policy Risks

The Board of Directors has determined that having an independent director serve as Chairman of the Board is in the best interests of our shareholders. This structure provides for a greater role for the independent directors in the oversight of Methode and active participation of the independent directors in setting agendas and establishing priorities and procedures for the work of the Board.

The Nominating and Governance Committee oversees the annual Board and committee evaluation process. Each year, our independent directors complete a written evaluation which focuses on Board practices, processes and skills, and seeks input on opportunities for improvement. To protect the directors’ anonymity and the integrity of the process, the directors send their completed evaluations directly to outside legal counsel. Legal counsel compiles the responses into a written report, which is then distributed to, and discussed by, the Nominating and Governance Committee and the full Board.

Our Board of Directors oversees Methode’s risk management practices. Our Board and committees review information regarding Methode’s markets, competition and financial risks, as well as risks associated with Methode’s operations Methode’s employees and political risks encountered by Methode throughout the world. Our Audit Committee discusses with management Methode’s major financial risk exposures and the steps management has taken to monitor and control such exposures, and reviews the process by which risk is managed and assessed. Our Audit Committee also reviews the Company’s cyber-security and information technology practices and policies. Our Compensation Committee evaluates risks arising from Methode’s compensation practices and policies. Our Nominating and Governance Committee reviews and evaluates Methode’s policies and practices with respect to risk management and risk assessment in areas such as business operations, human resources, international operations and

intellectual property. The entire Board of Directors is regularly informed about the risk management policies and practices monitored by the various committees. The Board of Directors also receives reports directly from officers responsible for assessing and managing particular risks within Methode.

We believe that risks arising from our compensation policies and practices for our employees are not reasonably likely to have a material adverse effect on Methode. The Compensation Committee monitors the mix and design of the elements of executive compensation and believes that our compensation programs do not encourage management to assume excessive risks.

Nominating Process of the Nominating and Governance Committee

Our Nominating and Governance Committee is responsible for identifying and recommending to our Board of Directors individuals qualified to become directors consistent with criteria approved by our Board. In considering potential candidates for our Board, including with respect to nominations for re-election of incumbent directors, the Committee considers the potential candidate’s integrity and business ethics; strength of character, judgment and experience consistent with our needs; specific areas of expertise and leadership roles; and the ability to bring diversity to our Board. While the Nominating and Governance Committee charter and our Corporate Governance Guidelines do not prescribe diversity standards, the Committee considers diversity in the context of the Board as a whole, including whether the potential candidate brings complementary skills and viewpoints. The Committee also considers the ability of the individual to allocate the time necessary to carry out the tasks of Board membership, including membership on appropriate committees. The Committee seeks an appropriate balance between newer directors and longer-serving directors. Two of our current ten independent directors were added in the last year. The Committee and the Board expect to add two more new independent directors by our 2020 annual meeting of shareholders.

5

The Committee identifies potential nomineeshas adopted a process for identifying new director candidates. Recommendations may be received by asking currentthe Committee from various sources, including directors and others to notifyCompany contacts. In the event the Committee if they become aware of persons, meeting the criteria described above, who may be availabledeems it appropriate to serve on our Board. The Committeeengage a search firm, it has sole authority to retain and terminate any such search firm used to identify director candidates and has sole authority to approve the search firm’s fees and other retention terms. Historically,fees. In June 2018, the Committee has not engaged third partiesretained a search firm to assist in identifying and evaluating potential nominees, but would do so in those situations where particular qualifications are required to fill a vacancy and our Board’s contacts are not sufficient to identify an appropriate candidate.with the independent director recruitment process.

The Committee will also consider suggestions from our shareholders. Any recommendations received from shareholders will be evaluated in the same manner that potential nominees suggested by Board members are evaluated. Upon receiving a shareholder recommendation, the Committee will initially determine the need for additional or replacement Board members and evaluate the candidate based on the information the Committee receives with the shareholder recommendation or may otherwise acquire, and may, in its discretion, consult with the other members of our Board. If the Committee determines that a more comprehensive evaluation is warranted, the Committee may obtain additional information about the director candidate’s background and experience, including by means of interviews with the candidate.

Our shareholdersShareholders may recommend candidates at any time, but the Committee requires recommendations for election at anour annual meeting of shareholders to be submitted to the Committee no later than 120 days before the first anniversary of the date of the proxy statement in connection withfrom the previous year’s annual meeting. The Committee believes this deadline is appropriate and in the best interests of Methode and our shareholders because it ensures that the Committee has sufficient time to properly evaluate all proposed candidates. Therefore, to submit a candidate for consideration for nomination at the 2018 annual meeting of shareholders, a shareholder must submit the recommendation, in writing, by April 3, 2018. The written notice must include:

include (i) the name, age, business address and residential address of each proposed nominee and the principal occupation or employment of each nominee;
the proposed nominee, (ii) the number of shares of our common stock that eachowned by such nominee, beneficially owns;
(iii) a statement that eachthe nominee is willing to be nominated;nominated, and
(iv) any other information concerning each nominee that would be required under the rules of the SEC in a proxy statement soliciting proxies forunder the election of those nominees.

SEC’s rules. Recommendations must be sent to the Nominating and Governance Committee, Methode Electronics, Inc., 74018750 West WilsonBryn Mawr Avenue, Suite 1000, Chicago, Illinois 60706.60631. Any recommendations from shareholders will be evaluated in the same manner that potential nominees suggested by directors or Company contacts are evaluated. Information regarding the requirements to nominate a director at our 20182020 Annual Meeting are set forth below under “Other Information -- Information—Shareholder Proposals and Director Nominations.”

Communications with Directors

Our annual meeting of shareholders provides an opportunity each year for shareholders to ask questions of, or otherwise communicate directly with, members of our Board of Directors on appropriate matters. All of our directors attended the 20162018 annual meeting. We anticipate that all of our directors will attend the 20172019 annual meeting.

In addition, interested parties may, at any time, communicate in writing with any particular director, or our independent directors as a group, by sending such written communication to the Corporate Secretary of Methode Electronics, Inc. at 74018750 West WilsonBryn Mawr Avenue, Suite 1000, Chicago, Illinois 60706.60631. Copies of written communications received at such address will be provided to the relevant director or the independent directors as a group unless such communications are considered, in the reasonable judgment of the Corporate Secretary, to be improper for submission to the intended recipient(s). Examples of shareholder communications that would be considered improper for submission include, without limitation, customer complaints, solicitations, communications that do not relate directly or indirectly to us or our business or communications that relate to other improper or irrelevant topics.

Code of Business Conduct and Ethics

Our Board of Directors has adopted a Code of Business Conduct that applies to our directors, principal executive officer, principal financial officer, principal accounting officer or controller and persons performing similar functions, as well as other employees. The codeCode is available on our website atwww.methode.com or in print upon any shareholder’s request.

If we make any substantive amendments to the Code of Business Conduct or grant any waiver, including any implicit waiver, from a provision of the Code of Business Conduct to our principal executive officer, principal financial officer, principal accounting officer or controller or persons performing similar functions, we will disclose the nature of such amendment or waiver on our website or in a report on Form 8-K in accordance with applicable rules and regulations.

Director Stock Ownership Guidelines

Our Compensation Committee considers stock ownership by directors to be an important means of linking their interests with those of our shareholders. We maintain stock ownership guidelines for our directors. All directors are expected to own stock with a value equal to at least five times the annual cash retainer paid to Methode directors. The requirements aredirectors, subject to a five-year phase-in period. All of our directors were in compliance with our stock ownership guidelines for fiscal 2017.2019.

6

DIRECTOR COMPENSATION

We use a combination of cash and common stock to compensate our non-employee directors. Directors who are also our full-time employees are not paid for their services as directors or for attendance at meetings.

For the fiscal year ended April 29, 2017,27, 2019, our non-employee directors received an annual cash retainer of $44,000 and an attendance fee of $1,000 per committee meeting and for each board meeting other than the regularly scheduled quarterly meetings. In addition, in July 2016,2018, the Compensation Committee, upon the recommendation of the Nominating and Governance Committee, granted each non-employee director serving at such time a stock award for 3,000 shares of common stock. Our Chairman of the Board and the Chair of each of our standing board committees received supplemental annual cash retainers in the following amounts: Chairman of the Board, $30,000; Chair of each of the Audit Committee and the Compensation Committee, $24,000; and Chair of each of the Nominating and Governance Committee and the Technology Committee, $12,000. In addition, members of our Audit Committee and Compensation Committee (other than the Chair) received an additional annual cash retainer of $10,000. Pursuant to our Deferred Compensation Plan, our directors may elect to defer up to 100% of their cash retainers and attendance fees per year. Additional information regarding the Deferred Compensation Plan is described under “Executive Compensation — Nonqualified Deferred Compensation” below.

The following table sets forth certain information regarding compensation earned by our non-employee directors during the fiscal year ended April 29, 2017.27, 2019.

NameName

Fees Earned

or Paid in Cash

($)

Stock Awards

($) (1)

Total

($)

Fees Earned
or Paid in Cash
($)
Stock Awards
($)(1)
Total
($)
Martha Goldberg Aronson
 
88,000
 
 
116,250
 
 
204,250
 
Walter J. AspatoreWalter J. Aspatore111,270 102,870  214,140
 
119,000
 
 
116,250
 
 
235,250
 
Warren L. Batts70,770   102,870   173,640
Brian J. Cadwallader
 
75,000
 
 
116,250
 
 
191,200
 
Darren M. DawsonDarren M. Dawson84,270   102,870  187,140
 
90,000
 
 
116,250
 
 
206,250
 
Stephen F. Gates101,770   102,870   204,640
Martha Goldberg Aronson69,770  102,870   172,640
Isabelle C. GoossenIsabelle C. Goossen101,270   102,870   204,140
 
108,000
 
 
116,250
 
 
224,250
 
Christopher J. HornungChristopher J. Hornung78,770  102,870   181,640
 
80,000
 
 
116,250
 
 
196,250
 
Paul G. SheltonPaul G. Shelton87,270   102,870   190,140
 
90,000
 
 
116,250
 
 
206,250
 
Lawrence B. SkatoffLawrence B. Skatoff80,770   102,870  183,640
 
78,000
 
 
116,250
 
 
194,250
 
    
         
(1)(1)The reported amounts reflect the fair value at the date of grant calculated in accordance with the Financial Accounting Standards Board’s Accounting Standards Codification Topic 718. Details of the assumptions used in valuing these awards are set forth in Note 4 to our audited financial statements included in our Annual Report on Form 10-K for the fiscal year ended April 29, 2017.27, 2019.

(2)Directors Crowther and Schwabero were elected to the Board in June, 2019 and will be compensated in a manner consistent with the Company’s other independent directors.

7

SECURITY OWNERSHIP

Five Percent Shareholders

The following table sets forth information regarding all persons known by Methode to be the beneficial owners of more than 5% of Methode’s common stock as of July 17, 2017.18, 2019.

Name and Address of Beneficial OwnerAmount and Nature
of Beneficial Ownership
Percent of Class (%)

BlackRock, Inc. (1)

55 East 52nd Street

New York, New York 10055

4,106,67011.2

The Vanguard Group (2)

100 Vanguard Blvd.

Malvern, Pennsylvania 19355

3,040,5638.3

The Bank of New York Mellon Corporation (3)

225 Liberty Street

New York, New York 10286

2,853,7387.8

Dimensional Fund Advisors LP (4)

Building One

6300 Bee Cave Road

Austin, TX 78746

2,049,4465.6

Name and Address of Beneficial Owner
Amount and Nature of
Beneficial Ownership
Percent of Class (%)
BlackRock, Inc.(1)
55 East 52nd Street
New York, New York 10055
 
5,403,585
 
 
14.6
 
The Vanguard Group(2)
100 Vanguard Blvd.
Malvern, Pennsylvania 19355
 
3,727,168
 
 
10.1
 
Dimensional Fund Advisors LP(3)
Building One
6300 Bee Cave Road
Austin, TX 78746
 
2,044,384
 
 
5.5
 
(1)Information is based on a Schedule 13G/A filed with the Securities and Exchange Commission (“SEC”) on January 31, 2019. In the Schedule 13G/A, BlackRock, Inc. reported that, as a parent holding company, as of December 31, 2018, it had sole voting power with respect to 5,317,494 shares and sole dispositive power with respect to 5,403,585 shares.
(1)(2)Information is based on a Schedule 13G/A filed with the SEC on January 12, 2017.  In the Schedule 13G/A, BlackRock, Inc. reported that, as of December 31, 2016, it had sole voting power with respect to 4,027,468 shares and sole dispositive power with respect to 4,106,670 shares.
(2)Information is based on a Schedule 13G/A filed with the SEC on February 10, 2017.2019. In the Schedule 13G/A, The Vanguard Group reported that, as of December 31, 2016,2018, it had sole voting power with respect to 70,19455,988 shares, shared voting power with respect to 5,559 shares, sole dispositive power with respect to 2,966,7153,671,159 shares and shared dispositive power with respect to 73,84856,009 shares. Vanguard Fiduciary Trust Company, a wholly-owned subsidiary of The Vanguard Group, Inc., is the beneficial owner of 68,28950,450 shares of the Company’s common stock as a result of its serving as investment manager of collective trust accounts. Vanguard Investments Australia, Ltd., a wholly-owned subsidiary of The Vanguard Group, Inc., is the beneficial owner of 7,46411,097 shares of the Company’s common stock as a result of its serving as investment manager of Australian investment offerings.
(3)Information is based on a Schedule 13G/A filed with the SEC on February 3, 2017.  In the Schedule 13G/A, The Bank of New York Mellon Corporation reported that, as of December 31, 2016, it had sole voting power with respect to 2,759,957 shares, sole dispositive power with respect to 2,826,838 shares and shared dispositive power with respect to 26,900 shares.  The Schedule 13G/A reported that all of the shares are beneficially owned by The Bank of New York Mellon Corporation and its direct or indirect subsidiaries in their various fiduciary capacities (including as an investment adviser or a broker or dealer).
(4)Information is based on a Schedule 13G/A filed with the SEC on February 9, 2017.8, 2019. In the Schedule 13G/A, Dimensional Fund Advisors LP reported that it is an investment advisor and, as of December 31, 2016,2018, it had sole voting power with respect to 1,949,2761,934,428 shares and sole dispositive power with respect to 2,049,4462,044,384 shares.


Directors and Executive Officers

The following table sets forth information regarding our common stock beneficially owned as of July 17, 201718, 2019 by (i) each director and nominee, (ii) each of the named executive officers, and (iii) all current directors and executive officers as a group.

Name of Beneficial OwnerAmount and Nature of Beneficial Ownership (1)Percent of Class (%)
Walter J. Aspatore27,000(2) *
Warren L. Batts76,000 *
Darren M. Dawson13,000 *
Donald W. Duda631,364(3) 1.7
Martha Goldberg Aronson6,000 (4) *
Isabelle C. Goossen43,450 *
Christopher J. Hornung37,850 *
Paul G. Shelton42,850 *
Lawrence B. Skatoff39,350(5) *
Timothy R. Glandon43,079(6) *
John R. Hrudicka72,000(7) *
Joseph E. Khoury240,600(8) *
Theodore P. Kill211,830(9) *
Douglas A. Koman119,792(10) *
All current directors and executive officers as a group1,604,165(11) 4.4

Name of Beneficial Owner
Amount and Nature of
Beneficial Ownership(1)
Percent of Class (%)
Martha Goldberg Aronson
 
12,000
(2) 
*
Walter J. Aspatore
 
33,000
(3) 
*
Brian J. Cadwallader
 
6,000
 
*
Bruce K. Crowther
 
3,000
 
*
Darren M. Dawson
 
16,000
 
*
Donald W. Duda
 
809,882
(4) 
2.1
Isabelle C. Goossen
 
43,450
 
*
Christopher J. Hornung
 
52,050
 
*
Mark D. Schwabero
 
3,000
 
*
Paul G. Shelton
 
47,850
 
*
Lawrence B. Skatoff
 
44,350
(5) 
*
Michael Brotherton
 
82,444
(6) 
*
Joseph E. Khoury
 
283,500
(7) 
*
Anil Shetty
 
84,306
(8) 
*
Ronald L.G. Tsoumas
 
108,801
(9) 
*
All current directors and executive officers as a group
 
1,700,012
(10) 
4.4
*Percentage represents less than 1% of the total shares of common stock outstanding.

8

(1)(1)Beneficial ownership arises from sole voting and dispositive power unless otherwise indicated by footnote.
(2)Shares are held in a trust pursuant to which Ms. Goldberg Aronson shares voting and investment power with her husband.
(3)Includes 15,00024,000 shares held jointly with Mr. Aspatore’s wife.
(3)(4)Includes 19,55213,979 shares held jointly with Mr. Duda’s wife, options to purchase 40,000 shares of common stock exercisable within 60 days, 201,812195,055 shares of vested restricted stock units for which common stock will be delivered to Mr. Duda at such time as the value of the award is deductible by us or Mr. Duda’s employment terminates, 100,000172,000 shares of vested restricted stock units for which common stock will be delivered to Mr. Duda in the event of termination from Methode under any circumstance, and 270,000 shares of performance-based restricted stock subject to forfeiture.  
(4)Shares areforfeiture and 70,848 shares of common stock held in a trust pursuant to which Ms. Goldberg Aronson shares voting and investment power with her husband.our 401(k) Plan.
(5)(5)Shares are held in a trust pursuant to which Mr. Skatoff shares voting and investment power with his wife.
(6)Includes 54,000 shares of performance-based restricted stock subject to forfeiture, options to purchase 1,668 shares of common stock exercisable within 60 days and 458 shares of common stock held in our 401(k) Plan.
(7)Includes options to purchase 12,000 shares of common stock exercisable within 60 days, 1,079 shares of common stock held in our 401(k) Plan and 30,000 shares of vested restricted stock units for which common stock will be delivered to Mr. Glandon in the event of termination from Methode under any circumstance. 
(7)Includes 72,000 shares of performance-based restricted stock subject to forfeiture. 
(8)Includes options to purchase 12,000 shares of common stock exercisable within 60 days, 30,00066,000 shares of vested restricted stock units for which common stock will be delivered to Mr. Khoury in the event of termination from Methode under any circumstance and 135,000 shares of performance-based restricted stock subject to forfeiture.
(9)(8)Includes 34,83054,000 shares held jointly with Mr. Kill’s wife,of performance-based restricted stock subject to forfeiture and options to purchase 12,0005,000 shares of common stock exercisable within 60 days.
(9)Includes options to purchase 8,000 shares of common stock exercisable within 60 days, 30,0009,300 shares of common stock held in our 401(k) Plan, 33,200 shares of vested restricted stock units for which common stock will be delivered to Mr. KillTsoumas in the event of termination from Methode under any circumstancecircumstances and 135,00049,500 shares of performance-based restricted stock subject to forfeiture.
(10)Includes 94,32237,979 shares held jointly, with Mr. Koman’s wife and 25,470 shares of performance-based restricted stock subject to forfeiture.
(11)Includes 163,704 shares held jointly, 34,83056,350 shares held in trust with voting and investment power shared with a spouse, options to purchase 76,00076,668 shares of common stock exercisable within 60 days, 1,07980,606 shares of common stock held in our 401(k) Plan, 391,812466,255 shares of vested restricted stock units and 637,470571,100 shares of performance-based restricted stock subject to forfeiture.

10 

9

PROPOSAL ONE
ELECTION OF DIRECTORS

A Board of eight directors will be elected at the annual meeting. Each director will hold office until the next annual meeting of shareholders and until his or her successor is elected and qualified. All of the nominees listed below currently serve as directors. All of the nominees were recommended unanimously to our Board of Directors by our Nominating and Governance Committee and were nominated by our Board of Directors. Mr. BattsIf any nominee is unwilling or unable to serve as a director, an event which our Board does not anticipate, shares represented by the proxies will be voted for the election of another nominee nominated by our Board upon the recommendation of our Nominating and Governance Committee, or the Board may reduce the number of directors to be elected at the annual meeting. Ms. Goldberg Aronson and Messrs. Hornung and Shelton are not be standing for re-election, and the Board expressed its great appreciation for all of the contributions he hasthey have made over the years. The size of the Board will be reduced from nineeleven directors to eight directors as of the date of the annual meeting. If any of these nominees is not a candidate for election at the annual meeting, an event which our Board of Directors does not anticipate, the proxies will be voted for a substitute nominee recommended to our Board of Directors by our Nominating and Governance Committee and nominated by our Board of Directors.

OUR BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” THE ELECTION OF THE FOLLOWING NOMINEES.

Walter J. Aspatore, Chairman

Chairman Emeritus,

Amherst Partners, LLC

Director since 2008

Age 74

Mr. Aspatore has served as Chairman Emeritus of Amherst Partners, LLC, a business consulting firm, since 2010. Prior thereto, Mr. Aspatore was Chairman of Amherst Partners from 1994 through 2010. Mr. Aspatore has served as Chairman of our Board since 2012. Prior to co-founding Amherst Partners, Mr. Aspatore served in various officer positions at diversified manufacturing and technology businesses, including Cross and Trecker Corporation, the Warner and Swasey Company, Bendix Corporation and TRW Corporation. He also served as Vice Chairman and President of Onset BIDCO, a venture capital and subordinated debt fund, from 1992 to 1994. Mr. Aspatore also serves as a director of Mackinac Financial Corporation, a bank holding company. Mr. Aspatore’s consulting experience and service at various consulting, manufacturing and technology businesses has resulted in continued contributions to the Board.

Dr. Darren M. Dawson

Leroy C. and Aileen H. Paslay Dean,

College of Engineering,

Kansas State University

Director since 2004

Age 54

Dr. Dawson has served as the Dean of the College of Engineering of Kansas State University since July, 2014. Prior thereto, Dr. Dawson served as a Professor in the Electrical and Computer Engineering Department at Clemson University, where he held various professor positions since 1990. His research interests include nonlinear control techniques for mechatronic systems, robotic manipulator systems and vision-based systems. Dr. Dawson’s work has been recognized by several awards, including the Clemson University Centennial Professorship in 2000. Dr. Dawson’s academic and technical background has provided the basis for continued contributions to the Board’s operations and deliberations.

Donald W. Duda

Chief Executive Officer and President,

Methode Electronics, Inc.

Director since 2001

Age 62

Mr. Duda has served as our Chief Executive Officer since 2004 and our President since 2001. Mr. Duda joined us in 2000 and served as our Vice President - Interconnect Products Group. Prior to joining Methode, Mr. Duda held several positions with Amphenol Corporation, a manufacturer of electronic connectors, most recently as General Manager of its Fiber Optic Products Division from 1988 through 1998. Mr. Duda has used his executive background and unique understanding of Methode to contribute

Walter J. Aspatore, Chairman
Chairman Emeritus
Amherst Partners, LLC
Director since 2008
Age 76

Mr. Aspatore has served as Chairman Emeritus of Amherst Partners, LLC, a business consulting firm, since 2010. Prior thereto, Mr. Aspatore was Chairman of Amherst Partners from 1994 through 2010. Mr. Aspatore has served as Chairman of our Board since 2012. Prior to co-founding Amherst Partners, Mr. Aspatore served in various officer positions at diversified manufacturing and technology businesses, including Cross and Trecker Corporation, the Warner and Swasey Company, Bendix Corporation and TRW Corporation. He also served as Vice Chairman and President of Onset BIDCO, a venture capital and subordinated debt fund, from 1992 to 1994. Mr. Aspatore also serves as a director of Mackinac Financial Corporation, a bank holding company. Mr. Aspatore’s consulting experience and service at various consulting, manufacturing and technology businesses has resulted in continued contributions to the Board.

Brian J. Cadwallader
Retired Vice President and General Counsel
Johnson Controls, Inc.
Director since 2018
Age 60

Mr. Cadwallader served as Vice President, Corporate Secretary and General Counsel of Johnson Controls, Inc. from 2014 to 2016. Prior thereto, Mr. Cadwallader served as Vice President and Assistant General Counsel of Johnson Controls from 2011 to 2014. Mr. Cadwallader served as Group Vice President and General Counsel of Johnson Controls’ Building Efficiency business from 2010 to 2011. Prior to joining Johnson Controls, Mr. Cadwallader served as Associate General Counsel and Assistant Secretary at International Paper Company. In addition to his other responsibilities, Mr. Cadwallader was responsible for international legal and regulatory affairs for Johnson Controls and International Paper for over 15 years. Mr. Cadwallader’s legal background with expertise in international operations, corporate governance, M&A and executive compensation has led to significant contributions to the Board.

Bruce K. Crowther
Retired Chief Executive Officer
Northwest Community Healthcare
Director since June, 2019
Age 67

Mr. Crowther served as President and Chief Executive Officer of Northwest Community Healthcare from 1992 until his retirement in 2013. Prior thereto, Mr. Crowther served as Executive Vice President and Chief Operating Officer of Northwest Community Healthcare from 1989 to 1991. Mr. Crowther is the past Chairman of the board of directors of the Illinois Hospital Association. Mr. Crowther serves as a director of NeoGenomics, Inc., Wintrust Financial Corporation and Barrington Bank. Mr. Crowther’s extensive leadership experience and significant knowledge regarding the healthcare industry has provided valuable insights to the Board.

11 

Martha Goldberg Aronson

Former Executive Vice President and President of Global Healthcare

Ecolab, Inc.

Director since April 2016

Age 49

Ms. Goldberg Aronson served from 2012 to 2016 as Executive Vice President and President, Global Healthcare, at Ecolab, Inc., a specialty chemical company. From 2010 to 2012, Ms. Goldberg Aronson was President, North America at Hill-Rom Holdings, Inc., a global medical technology company. Prior to Hill-Rom, Ms. Goldberg Aronson spent 18 years at Medtronic, Inc., a medical technology provider, most recently serving as Senior Vice President and Chief Talent Officer. Ms. Goldberg Aronson is currently a member of the Board of Directors of Cardiovascular Systems, Inc., Conmed Corporation and the Guthrie Theater. Ms. Goldberg Aronson served as a director of Hutchinson Technology, Inc. from 2010 through 2016. Based on her extensive leadership experience and experience in the global health care markets, Ms. Goldberg Aronson has provided valuable insights to the Board.

Isabelle C. Goossen

Retired Vice President and Chief Financial Officer,

Chicago Symphony Orchestra Association

Director since 2004

Age 65

Ms. Goossen served as the Chief Financial Officer for the Chicago Symphony Orchestra Association from March, 2011 thru March, 2017. Ms. Goossen served as the Vice President for Finance and Administration for the Chicago Symphony Orchestra Association from 2001 thru March, 2017. From 1986 through 1999, Ms. Goossen held several management positions with Premark International, Inc., a diversified consumer products company, most recently as Vice President and Treasurer from 1996 through 1999. Ms. Goossen serves as a director of the Columbian Financial Group, the parent company of Columbian Mutual Life Insurance and Columbian Life Insurance Company, each a life insurance company. In addition, Ms. Goossen is a trustee of Knox College and a director of the Cook County Health Foundation. Ms. Goossen has used her financial expertise and management background to make continued contributions to the Board.

Christopher J. Hornung, Vice Chairman

Co-Founder,

Sturbridge Capital

Director since 2004

Age 65

Mr. Hornung co-founded Sturbridge Capital, an investment fund, in 2011. Mr. Hornung served as Chairman of Doskocil Manufacturing Company Inc., doing business as Petmate, a producer and distributor of pet products, from 2010 to May, 2017. Prior thereto, Mr. Hornung served as Chief Executive Officer of Next Testing, Inc., a provider of comprehensive, sport-specific athletic testing programs, from January 2007 to November 2013. From February 2004 through December 2006, Mr. Hornung served as President of the Pacific Cycle Division of Dorel Industries, Inc., a global consumer products company. Prior to the acquisition of Pacific Cycle by Dorel Industries Inc., Mr. Hornung served as the Chairman and Chief Executive Officer of Pacific Cycle. Mr. Hornung is a recipient of the Ernst & Young Entrepreneur of the Year Award and serves on an advisory board of the University of Wisconsin School of Business. His executive and entrepreneurial experience as well as his expertise regarding international sourcing and distribution has resulted in continued contributions to the Board. 

12 

10

Paul G. Shelton

Retired Vice President and Chief Financial Officer,

FleetPride, Inc.

Director since 2004

Age 67

Mr. Shelton retired in 2003 as Vice President and Chief Financial Officer of FleetPride Inc., an independent heavy-duty truck parts distributor. From 1981 through 2001, Mr. Shelton served in various management positions at AMCOL International Corporation, a supplier of specialty minerals and chemicals, most recently as Senior Vice President from 1994 through 2001 and Chief Financial Officer from 1984 through 2001. Mr. Shelton serves on two private company boards and was a former member of the board of directors of AMCOL International Corporation and six private companies. Mr. Shelton has used his executive, financial and board experience to contribute to the operations and deliberations of the Board. 

Lawrence B. Skatoff

Retired Executive Vice President and Chief Financial Officer,

BorgWarner Inc.

Director since 2004

Age 77

Mr. Skatoff retired in 2001 as Executive Vice President and Chief Financial Officer of BorgWarner Inc., a manufacturer of highly engineered systems and components for the automotive industry. Prior to joining BorgWarner Inc., Mr. Skatoff was Senior Vice President and Chief Financial Officer of Premark International, Inc., a diversified consumer products company, from 1991 through 1999. Before joining Premark, Mr. Skatoff was Vice President-Finance of Monsanto Company, a worldwide manufacturer of chemicals and pharmaceuticals. Mr. Skatoff’s executive experience and financial background has led to continued contributions to the Board.

13 

Dr. Darren M. Dawson
President
The University of Alabama in Huntsville
Director since 2004
Age 56

Dr. Dawson has served as the President of The University of Alabama in Huntsville since April, 2019. Prior thereto, Dr. Dawson served as Dean of the College of Engineering of Kansas State University since 2014. From 1990 to 2014, Dr. Dawson served as a Professor in the Electrical and Computer Engineering Department at Clemson University. His research interests included nonlinear control techniques for mechatronic systems, robotic manipulator systems and vision-based systems. Dr. Dawson’s work has been recognized by several awards, including the Clemson University Centennial Professorship in 2000. Dr. Dawson’s academic and technical background has provided the basis for continued contributions to the Board’s operations and deliberations.

Donald W. Duda
Chief Executive Officer and President
Methode
Director since 2001
Age 64

Mr. Duda has served as our Chief Executive Officer since 2004 and our President since 2001. Mr. Duda joined us in 2000 and served as our Vice President - Interconnect Products Group. Prior to joining Methode, Mr. Duda held several positions with Amphenol Corporation, a manufacturer of electronic connectors, most recently as General Manager of its Fiber Optic Products Division. Mr. Duda has used his executive background and unique understanding of Methode to contribute to the Board.

Isabelle C. Goossen
Retired Vice President and Chief Financial Officer
Chicago Symphony Orchestra Association
Director since 2004
Age 67

Ms. Goossen served as the Chief Financial Officer for the Chicago Symphony Orchestra Association from 2011 thru 2017. Ms. Goossen served as the Vice President for Finance and Administration for the Chicago Symphony Orchestra Association from 2001 thru 2017. From 1986 through 1999, Ms. Goossen held several management positions with Premark International, Inc., most recently as Vice President and Treasurer. Ms. Goossen serves as a director of the Columbian Financial Group, the parent company of Columbian Mutual Life Insurance and Columbian Life Insurance Company, each a life insurance company. In addition, Ms. Goossen is a trustee of Knox College and a director of the Cook County Health Foundation. Ms. Goossen has used her financial expertise and management background to make continued contributions to the Board.

Mark D. Schwabero
Retired Chairman and Chief Executive Officer
Brunswick Corporation
Director since June, 2019
Age 67

Mr. Schwabero served as Chairman, Chief Executive Officer and Director of Brunswick Corporation from 2016 until his retirement in December, 2018. Prior thereto, Mr. Schwabero served as President and Chief Operating Officer of Brunswick Corporation from 2014 to 2016 and as President of its Mercury Marine subsidiary from 2008 to 2014. Mr. Schwabero serves on the Advisory Committee of The Ohio State University Center for Automotive Research and is a director of 1st Source Corporation. Mr. Schwabero’s leadership experience, international expertise and detailed knowledge of the automotive and industrial industries has provided valuable insights to the Board.

11

Lawrence B. Skatoff
Retired Executive Vice President and Chief Financial Officer
BorgWarner Inc.
Director since 2004
Age 79

Mr. Skatoff retired in 2001 as Executive Vice President and Chief Financial Officer of BorgWarner Inc. Prior to joining BorgWarner Inc., Mr. Skatoff was Senior Vice President and Chief Financial Officer of Premark International, Inc. from 1991 through 1999. Before joining Premark, Mr. Skatoff was Vice President-Finance of Monsanto Company. Mr. Skatoff’s executive experience and financial background has led to continued contributions to the Board.

12

PROPOSAL TWO
RATIFICATION OF SELECTION OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Audit Committee of our Board of Directors is directly responsible for the appointment, termination, compensation, evaluation and oversight of our independent registered public accounting firm. Our Audit Committee has selected Ernst & YoungEY to serve as our independent registered public accounting firm for the fiscal year ending April 28, 2018,May 2, 2020, subject to ratification of the selection by our shareholders. Ernst & YoungEY has served as our independent registered public accounting firm for many years and is considered to be well qualified.

Representatives of Ernst & YoungEY will be present at the annual meeting, will have the opportunity to make a statement and will be available to respond to appropriate questions.

If our shareholders do not ratify the selection of Ernst & Young,EY, our Audit Committee will reconsider the selection. Even if the selection is ratified, our Audit Committee may select a different independent registered public accounting firm at any time during the year if it determines that a change would be in the best interests of Methode and our shareholders.

OUR BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” THE RATIFICATION OF OUR AUDIT COMMITTEE’S SELECTION OF ERNST & YOUNGEY AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.

14 

13

proposalPROPOSAL THREE
advisorY
ADVISORY APPROVAL OF METHODE’S executive compensationEXECUTIVE COMPENSATION

Section 14A of the Securities Exchange Act of 1934 requires that we provide our shareholders with the opportunity to vote to approve, on a nonbinding, advisory basis, the compensation of our named executive officers as disclosed in this proxy statement, commonly known as a “say-on-pay” vote.

As described under “Executive Compensation – Compensation“Compensation Discussion and Analysis,” we seek to align the interests of our executives with the interests of our shareholders and reward performance.

The advisory vote on this resolution is not intended to address any specific element of compensation, but rather the overall compensation of our named executive officers as disclosed in this proxy statement. The vote is advisory, which means that the vote is not binding on Methode, our Board of Directors or our Compensation Committee. Although this vote is nonbinding, our Board of Directors and our Compensation Committee value the opinions of our shareholders and will consider the outcome of the vote when making decisions concerning executive compensation.

Shareholders may vote for or against the following resolution, or may abstain from voting. The affirmative vote of a majority of the shares present or represented at the annual meeting and entitled to vote is required to approve the proposed resolution.

We ask our shareholders to approve the following resolution:

      “RESOLVED, that the compensation of Methode’s named executive officers, as disclosed in Methode’s Proxy Statement for the 2019 Annual Meeting of Shareholders pursuant to the SEC’s compensation disclosure rules, including the Compensation Discussion and Analysis, the Summary Compensation Table and the other related tables and disclosure, is hereby approved.”

“RESOLVED, that the compensation of Methode’s named executive officers, as disclosed in Methode’s Proxy Statement for the 2017 Annual Meeting of Shareholders pursuant to the SEC’s compensation disclosure rules, including the Compensation Discussion and Analysis, the Summary Compensation Table and the other related tables and disclosure, is hereby approved.”

Our Board of Directors recommends a voteOUR BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” the approval of the THE APPROVAL OF THE FOREGOING RESOLUTION.

15 

PROPOSAL FOUR
ADVISORY VOTE ON THE FREQUENCY OF
FUTURE ADVISORY VOTES ON EXECUTIVE COMPENSATION

Section 14A of the Securities Exchange Act of 1934 provides that shareholders must be given the opportunity to vote, on a non-binding, advisory basis, on how frequently the advisory vote on executive compensation should be presented to our shareholders, commonly known as “say-on-pay” votes. Shareholders may indicate whether they would prefer that we conduct future “say-on-pay” votes once every one, two or three years. Shareholders also may abstain from casting a vote on this proposal.

We are required to hold an advisory vote regarding the frequency of “say-on-pay” votes every six years. The Company’s shareholders were provided with the opportunity to vote on the frequency of “say-on-pay” votes in 2011. At such time, the shareholders voted in favor of holding “say-on-pay” votes annually and the Board adopted this standard.

After consideration of each alternative, the Board recommends that the advisory vote on executive compensation continue to be submitted to the shareholders every year. Our Board of Directors has determined that an annual advisory vote on executive compensation will allow our shareholders to provide timely input on Methode’s executive compensation philosophy, policies and practices as disclosed in the proxy statement each year.

The proxy card provides shareholders with the opportunity to choose among four options (holding the vote every one, two or three years, or abstaining). Shareholders will not be voting to approve or disapprove the recommendation of the Board of Directors.

While this vote is advisory and not binding on Methode, the Board and the Compensation Committee expect to consider the outcome of the vote, along with other relevant information, in determining the frequency of future advisory votes on executive compensation. Notwithstanding the Board’s recommendation and the outcome of the shareholder vote, the Board may in the future decide to conduct advisory votes on a less frequent basis.

Our Board of Directors recommends a vote for a one-year frequency of the advisory vote on executive compensation. 

16 

14

AUDIT COMMITTEE MATTERS

Report of the Audit Committee

The Audit Committee oversees our financial reporting process on behalf of our Board of Directors. Our management has the primary responsibility for the financial statements and the reporting process, including the system of internal controls. Our Board has determined that each member of our Audit Committee meets the requirements as to independence, experience and expertise established by the New York Stock Exchange. Our Board has designated Mr. Aspatore, Ms. Goossen, Mr. Shelton and Mr. Skatoff as audit committee financial experts as defined by the SEC. In fulfilling its oversight responsibilities, our Audit Committee reviewed and discussed the audited financial statements in the Annual Report on Form 10-K for the year ended April 29, 201727, 2019 with management, including a discussion of the quality, not just the acceptability, of the accounting principles; the reasonableness of significant judgments; and the clarity of disclosures in the financial statements.

Our Audit Committee reviewed and discussed with our independent registered public accounting firm, Ernst & Young LLP (“EY”), which is responsible for expressing an opinion on the conformity of the audited financial statements with U.S. generally accepted accounting principles, the firm’s judgments as to the quality, not just the acceptability, of our accounting principles and such other matters as are required to be discussed under the standards of the Public Company Accounting Oversight Board (United States).

The Committee has received the written disclosures and the letter from Ernst & YoungEY required by applicable requirements of the Public Company Accounting Oversight Board regarding Ernst & Young’sEY’s communications with the Committee concerning independence, and has discussed with Ernst & YoungEY the firm’s independence from management and Methode and considered the compatibility of nonaudit services with the firm’s independence.

Our Audit Committee discussed with our internal auditors and Ernst & YoungEY the overall scope and plans for their respective audits. Our Audit Committee met with the internal auditors and Ernst & Young,EY, with and without management present, to discuss the results of their examinations, their evaluations of our internal controls, and the overall quality of our financial reporting. The Committee also discussed with Ernst & YoungEY the matters required to be discussed byunder the Public Company Accounting Oversight Board Auditing Standard No. 1301, Communications with Audit Committees - Public Company Accounting Oversight Board.

(AS 1301). In reliance on the reviews and discussions referred to above, the Committee recommended to our Board of Directors (and our Board has approved) that the audited financial statements be included in the Annual Report on Form 10-K for the year ended April 29, 201727, 2019 filed with the SEC.

AUDIT COMMITTEE

Isabelle C. Goossen, Chair

Walter J. Aspatore

Paul G. Shelton

Lawrence B. Skatoff

17 
AUDIT COMMITTEE
Isabelle C. Goossen, Chair
Walter J. Aspatore
Paul G. Shelton
Lawrence B. Skatoff

15

Auditing and Related Fees

Our Audit Committee engaged Ernst & Young to examine our consolidated financial statements for the fiscal year ended April 29, 2017.27, 2019. Fees paid to Ernst & Young for services performed during the 20172019 and 20162018 fiscal years were as follows:

  Fiscal 2017 Fiscal 2016
Audit Fees (1) $2,589,140 $1,960,702
Tax Fees (2) $25,593 $52,039
All Other Fees -- --
Total $2,614,733 $2,012,741

 
Fiscal 2019
Fiscal 2018
Audit Fees(1)
$
2,844,199
 
$
2,669,509
 
Tax Fees(2)
$
45,326
 
$
98,389
 
All Other Fees(3)
$
 
$
395,929
 
Total
$
2,889,525
 
$
3,163,827
 
(1)Audit fees represent aggregate fees billed for professional services rendered by Ernst & Young for the audit of our annual financial statements and review of our quarterly financial statements, audit services provided in connection with other statutory and regulatory filings and consultation with respect to various accounting and financial reporting matters and transaction advisory services.matters.
(2)(2)Tax fees primarily include fees for consultations regarding intercompany transfer pricing.
(3)
All other fees primarily includes fees related to due diligence on acquisition targets.

Pre-Approval Policy

Our Audit Committee is responsible for reviewing and pre-approving all audit and non-audit services provided by Ernst & Young and shall not engage Ernst & Young to perform non-audit services proscribed by law or regulation. In fiscal 2017,2019, 100% of audit and non-audit services were approved by the Audit Committee.

18 

16

COMPENSATION DISCUSSION AND ANALYSIS

Overview

This Compensation Discussion and Analysis describes the key elements of our executive compensation program, including an analysis of compensation awarded to, earned by or paid to our named executive officers in fiscal 2017.2019. Our fiscal 20172019 named executive officers included Donald W. Duda, Chief Executive Officer; John R. Hrudicka,Ronald L.G. Tsoumas, Chief Financial Officer; Joseph E. Khoury, Senior Vice President; Theodore P. Kill,Chief Operating Officer; Michael Brotherton, Vice President Worldwide Automotive Salesand President of Grakon; and Anil Shetty, Vice President and President of Dabir Surfaces; Timothy Glandon, Vice President;Surfaces. Messrs. Brotherton and Douglas Koman, our retired Chief Financial Officer. In July 2016, Mr. Koman resigned as Chief Financial Officer and Mr. Hrudicka was hired as our new Chief Financial Officer. Mr. Koman retired as an employeeShetty were appointed executive officers in September 2016.2018.

Executive Summary

Our Compensation Committee strives to provide compensation programs that align our executives’ interests with those of our shareholders and appropriately reward our executives for performance against annual and multi-year objectives.

The key elements of our fiscal 20172019 compensation program for our named executive officers included the following:

Salary. In reviewing fiscal 20172019 salaries for our named executive officers, our Compensation Committee discussed retention issues, reviewed advice from its independent compensation consultant regarding market practices and considered Mr. Duda’s recommendations for officers other than himself. The Compensation Committee also considered other relevant factors, including the individual performance, skills and experience of each executive, internal pay equity issues, executive retention, promotions, increased responsibilities, peer comparisons and the Company’s performance. After deliberation, the Compensation Committee increased Mr. Duda’s salary by 3% and Mr. Khoury’s salary by 10%. In establishing the new salaries for Messrs. Tsoumas, Brotherton and Shetty, the Compensation Committee also considered each officer’s recent promotion and significant increase in responsibilities. The Compensation Committee decidedincreased the salaries of our recently promoted named executive officers as follows: Mr. Tsoumas (promoted to increase the salary of each of Messrs. Duda, Khoury, Kill and Koman by 3.0%. The Compensation Committee set Mr. Hrudicka’s salary in connection with hiring him as our Chief Financial Officer.Officer), 63%; Mr. Brotherton (promoted to President of Grakon), 25%; and Mr. Shetty (promoted to President of Dabir Surfaces), 31%.
Annual Performance-Based Cash Bonus. After considering the guideline benchmark target, executive performance, retention issues, internal pay equity, market conditions, the advice of our independent compensation consultant and Mr. Duda’s recommendations for the other officers, the Compensation Committee madeset fiscal 20172019 annual performance-based cash bonus awards.opportunities. For Messrs.Mr. Duda, Hrudicka, Khoury and Koman,the target amount payable under the annual performance-based cash bonus was set at 100% of base salary. For all other executive officers, the amount payable at target was set at 66% of base salary. For all of our executive officers, 70% of the target bonus was based on an adjusted pre-tax income measure for the Company (excluding costs and earnings from the Grakon acquisition) and 30% was based on salesnew business bookings or revenue objectives and/or individual management objectives. For Mr. Kill, 25% of the target bonus was based on the Company pre-tax income measure and 75% was based on performance measures related to our Dabir Surface medical device products. The maximum amount payable with respect to the Company pre-tax income measuremeasures and new business objectives was set at 200% of the amount payable at the target level of performance, in order to alignwhich aligns the awardbonus opportunity with competitive practice among the peer group. Due to Mr. Koman’s retirement, he was entitled to a pro-rata payment of his annual bonus based on his retirement date and the performance achieved with respect to the measures described below. In connection with his hiring, Mr. Hrudicka was guaranteed a minimum bonus of $150,000 for fiscal 2017.
Fiscal 2016 LTILong-Term Incentive (“LTI”) Program. Our five-yearmulti-year, long-term equity program consists of a mix of 60% performance-based restricted stock awards (“RSAs”), at target performance, and 40% time-based restricted stock units (“RSUs”). The Compensation Committee expects the Fiscal 2016 LTI Program to cover all long-term incentive grants to the participants through the end of fiscal 2020 (i.e., five fiscal years).2020. The number of RSAs earned will be based on the achievement of established goals for the Company’s earnings before net interest, taxes, fixed asset depreciation and intangible asset amortization (“EBITDA”) for fiscal 2020. The EBITDA performance goals under the Fiscal 2016 LTI Program were designed to align with the Company’s targeted annual growth rate for EBITDA of 9% to 10% for the period.five-year period ending with fiscal 2020. The RSUs are subject to vesting based on continued service, with no RSUs vesting prior to the end of fiscal 2018, subject to acceleration in certain limited circumstances.

17

Our executive compensation program contains the following components and features that are designed to reflect compensation governance best practices and align the interests of our named executive officers and shareholders.

19 
No excessive post-termination benefits: Our executives do not participate in pension plans or receive other post-retirement benefits, nor do they generally have employment or severance agreements (other than in connection with a change of control).
No “single trigger” change of control benefits: We maintain “double-trigger” change of control agreements, and the executives are only entitled to a severance payment if an executive is terminated without cause or an executive terminates for good reason subsequent to a change of control. In addition, awards under our Fiscal 2016 LTI Program do not automatically vest upon a change in control.
No excise tax gross ups: We do not provide for gross-up payments for excise taxes our executive officers may incur in connection with a change of control.
Robust performance-based incentives: In general, a significant amount of each of our named executive officer’s compensation is variable compensation and “at risk” for non-payment if we fail or the executive fails to meet performance targets. Consistent with our pay-for-performance philosophy, approximately 56.5%53% of our Chief Executive Officer’s fiscal 20172019 compensation is composed of performance-based compensation, consisting of one-fifthan annualized portion of the grant date fair value of the fiscal 2016 performance-basedmulti-year LTI Program RSAs (at target performance), and the annual performance-based cash bonus.bonus for fiscal 2019 at target.
Disclosure of performance measures: We disclose the performance measures for the RSAs awarded pursuant to the Fiscal 2016outstanding under our LTI Program and our fiscal 20172019 performance-based annual bonuses in this Compensation Discussion and Analysis.
Equity compensation best practicesNo dividends or dividend equivalents on unearned awards: OurUnder our 2014 Omnibus Incentive Plan, contains certain restrictions that reflect sound corporate governance principles, including the following:
dividends on performance-based stock awards and dividend equivalents on performance-based stock unit awards are paid only to the extent the underlying awards vest; andare earned or vest.
awards to employees are subject to the following minimum vesting requirements: (i) stock options, performance-based restricted stock, restricted stock units or performance units − at least one year; and (ii) time-based restricted stock, restricted stock units or performance units − at least three years, with no more frequent than ratable vesting over the vesting period. The minimum vesting requirements are not applicable in the event vesting is accelerated under certain circumstances such as death or disability, and the plan provides for an exception to the minimum vesting requirement for up to ten percent (10%) of the number of shares authorized for issuance under the plan.

Use of an independent compensation consultant: The Compensation Committee directly engages an independent compensation consultant to review the competitiveness and effectiveness of our executive compensation program.program and to advise the Compensation Committee on regulatory and other current trends and key developments in executive compensation.
Executive officer stock ownership requirements: We require all of our executive officers to hold substantial amounts of our common stock. Our Chief Executive Officer is expected to own stock with a value at least equal to six (6) times his base salary, our Chief Operating Officer is expected to own stock with a value at least equal to three (3) times his base salary and other executive officers are expected to own two (2) times their base salary. The requirements are subject to a phase-in period in the event of a new hire or a promotion. In addition, for the majority of our executive officers, shares of common stock underlying thevested RSUs awarded under the Fiscal 2011 LTI Program (described below) and the Fiscal 2016 LTI Program will not be delivered to the executive until the earlier of the executive’s termination of employment or a change of control of Methode.
Incentive “clawback” policy: In the event we are required to restate our financial statements due to material noncompliance, our Incentive Compensation Recoupment Policy requires us to recover from our current or former executive officers certain amounts of incentive-based compensation paid within the prior three years.
Policy prohibiting hedging or pledging our stock: Our Insider Trading Policy prohibits our directors, executive officers and certain key employees from engaging in certain transactions involving our common stock, including options trading, short sales, derivative transactions and hedging transactions. In addition, these directors, executive officers and key employees are prohibited from holding our common stock in a margin account or otherwise pledging our common stock as collateral for a loan.
20 Annual say-on-pay advisory vote: We hold an annual advisory vote for our stockholders to review and approve our executive compensation program, which received 95% stockholder support last year.

prohibited from holding our common stock in a margin account or otherwise pledging our common stock as collateral for a loan.

18

Objectives and Measurement Principles

Our executive compensation program supports our objective of enhancing shareholder value through a competitive program that attracts and retains high-quality talent and rewards executives for demonstrating strong leadership and delivering results. Our executive compensation program is designed to:

Provide executives with a competitive pay arrangement.
Link short-term cash incentive pay to achievement of company objectives for pre-tax income and new sales,business bookings, and in certain cases, individual objectives.
Link long-term equity incentives to achievement of EBITDA objectives, as adjusted for certain acquisitions and divestitures.
Align executive interests with shareholder interests by providing for capital accumulation through awards of RSAs and RSUs and encourage significant ownership of our common stock by our executive officers.

Our Compensation Process

Our Overall Process.Our Compensation Committee is comprised entirely of independent directors and meets as often as necessary to perform its duties. In fiscal 2017,2019, our Compensation Committee met fivesix times. Our Compensation Committee typically meets with Donald W. Duda, our Chief Executive Officer.Officer, and reserves time at each meeting to hold an executive session without any members of management present.

Our Compensation Committee annually engages a compensation consultant to review the competitiveness and effectiveness of our executive compensation program and annually reviews summaries of our named executive officers’ compensation.compensation relative to peers and survey data. Our Compensation Committee also annually reviews company performance relative to peers and survey data.peers.

Our Chief Executive Officer’s compensation is determined by our Compensation Committee. Management does not make recommendations to our Compensation Committee regarding compensation elements with respect to Mr. Duda’s compensation. For named executive officers other than Mr. Duda, compensation packages are developed and recommended by Mr. Duda, in consultation with the Chief FinancialHuman Resources Officer, based on guidelines provided by our Compensation Committee. Our Compensation Committee determines whether to approve these recommendations, subject to any modifications that it may deem appropriate.

Role of Compensation Consultant. Since 2013, Frederic W. Cook & Co., Inc. (“FWC”FW Cook”) has provided independent executive compensation consulting services to the Compensation Committee. FWCFW Cook is retained by and reports to the Compensation Committee. During fiscal 2017, FWC2019, FW Cook provided the following services:

assisted the Compensation Committee in evaluating the linkage between pay and performance;
assisted the Compensation Committee in developing a compensation peer group to be used for evaluating compensation decisions;
provided and reviewed market data and advised the Compensation Committee on setting executive compensation and the competitiveness and reasonableness of the Company’s executive compensation program;
reviewed and advised the Compensation Committee regarding the elements of the Company’s executive compensation program, each as relative to the Company’s peers and survey data;
advised the Compensation Committee on setting compensation for Mr. Hrudicka, our new Chief Financial Officer;
provided information regarding realizable pay in light of our Fiscal 2016multi-year LTI Program;
evaluated the Company’s compensation programs and practices in relation to potential compensation risk areas to confirm that the risks inherent in the executive compensation program are not reasonably likely to have a material adverse effect on the Company; and
21 
reviewed and advised the Compensation Committee regarding regulatory, governance, disclosure and other technical matters.

The Compensation Committee reviewed information provided by FWCFW Cook addressing the independence of FWCFW Cook and the representatives serving the Committee. Based on this information, the Compensation Committee concluded that the work performed by FWCFW Cook and its representatives involved in the engagement did not raise any conflict of interest and that FWCFW Cook and such representatives are independent from the Company’s management.

19

Consideration of 20162018 Say-on-Pay Vote Results. At our 20162018 annual meeting, our shareholders approved our fiscal 20162018 executive compensation, with approximately 95% of voted shares cast in favor of the say-on-pay resolution. Our Compensation Committee considered the results of the 20162018 say-on-pay vote along with other factors when making executive compensation decisions.

Risk Assessment. The Compensation Committee, together with the Chief Executive Officer and its independent compensation consultant, annually considers potential risks when reviewing our compensation programs for all employees, including our executive officers. Based on this assessment, the Compensation Committee concluded that our fiscal 2019 compensation programs do not create risks that are reasonably likely to have a material adverse effect on the Company. In making this determination, the Compensation Committee reviewed the key features of our compensation programs and policies, including the following:

The Compensation Committee members are fully independent and supported by an outside independent compensation consultant.
Compensation for our executive officers is composed of salary, annual performance-based cash incentives and long-term equity incentives that are time-based and performance-based, representing a balanced mix.
Our incentive programs are designed to avoid an over emphasis on a single performance metric. The annual incentive awards reward the achievement of short-term profit, new business bookings, and individual performance objectives. The performance-based RSAs under the LTI Program are tied to a longer-term profitability growth objective. Incentive opportunities for non-executive employees (including sales employees) are market competitive and balanced with fixed compensation components.
The maximum amount payable under the annual performance-based cash bonuses with respect to the profit and sales objectives is capped at 200% of target.
Our LTI Program is comprised entirely of equity awards in order to directly align the interests of our executive officers with those of our shareholders. The award mix of 60% performance-based RSAs, at target performance, and 40% time-vested RSUs is intended to support the Company’s operating performance and retention objectives, respectively.
Our stock ownership policy requires significant stock ownership by our executive officers, which further aligns the interests of our executive officers with the long-term interests of our shareholders.
Our Incentive Compensation Recoupment Policy requires us to recover from our current or former executive officers certain amounts of incentive-based compensation in the event we are required to restate our financial statements due to material noncompliance.
Employees are subject to a Company policy that prohibits pledging and hedging activities with respect to Methode common stock.
Severance benefits are at appropriate levels to attract necessary talent, but not excessive, and the Company does not provide excise tax gross-ups.

Market Benchmarking and Positioning of Fiscal 20172019 Executive Compensation

We strive to provide compensation opportunities that are market competitive. In order to assist the Compensation Committee in achieving this objective for fiscal 2017, FWC2019, FW Cook was retained to conduct a review of our executive compensation peer group and benchmark our executive compensation program using a custom peer group and third-party survey data. The Compensation Committee considers this benchmarking information in reviewing each element of our compensation program.

After considering the advice of FWC,FW Cook, the Compensation Committee approved using the fiscal 20162018 peer group for fiscal 2017,2019, subject to a few modifications.one modification. One former peer company, Remy International, Inc.,IPG Photonics Corporation, was eliminated since it had been acquired. Two newis positioned well above the market capitalization range targeted for our peer companies, AVX Corporation and Multi-Fineline Electronix, Inc., were added. Each of the new peer companies satisfies the Compensation Committee’s criteria for the peer group as summarized below.companies.

The peer group used for benchmarking purposes in fiscal 20172019 was selected using the following criteria:

Size as measured by revenue – we generally targeted companies with revenue not less than half nor more thanone-half to two times our annual revenue.
Size as measured by market capitalization – we generally targeted companies with market capitalization not less than one-third nor more thanto three times our market capitalization.
Similar-type businesses – we generally targeted companies that are multinational and engage in businesses with similar technology, products and markets.

20

For compensation decisions affecting fiscal 20172019 compensation, the peer group included the following companies:

AVX Corporation
IPG Photonics
Kemet Corporation
Rogers Corporation
CTS Corporation
Littelfuse, Inc.
LCI Industries
Standard Motor Products, Inc.
Dorman Products, Inc.
MTS Systems Corporation
Littelfuse, Inc.
Stoneridge, Inc.
Drew Industries, IncorporatedMulti-Fineline Electronix, Inc.TTM Technologies, Inc.
Franklin Electric Company, Inc.
MTS Systems Corporation
TTM Technologies, Inc.
Gentherm Incorporated
OSI Systems, Inc.
Universal Electronics Inc.
Gentherm Incorporated


In benchmarking our compensation program for fiscal 2017,2019, the Compensation Committee also reviewed information compiled by FWCFW Cook from the followingmajor third-party executive pay surveys: (i) 2015 Mercer Executive Benchmark; (ii) 2015 Aon Hewitt Total Compensation Management; (iii) 2015 Willis Towers Watson U.S. Compensation Data Bank; and (iv) 2015 Willis Towers Watson Top Management.surveys.

As a general policy, we targeted fiscal 20172019 executive officer total direct compensation (salary, annual cash bonus and long-term incentive compensation) and each component thereof in the 50th50th to 75th75th percentile range of competitive practice, which aligned with the Company’s relative positioning in terms of revenues, net income and market capitalization versus its peer group. In making benchmarking determinations for fiscal 20172019 compensation, the Compensation Committee assumed that each executive would achieve the target level of performance under all performance-based awards. In addition, in valuing the RSA and RSU awards outstanding under the Fiscal 2016 LTI

22 

Program, the Compensation Committee assumed each executive would achieve the target level of performance under the RSAs and included one-fifth of the grant date fair valuean annualized portion of these shares in thesethe comparative calculations since the Fiscal 2016 LTI Program is intended to cover all long-term equity incentive grants to the participantsnamed executive officers from fiscal 2016 through fiscal 2020. For Mr. Hrudicka, one-fourthOne-fifth of the grant date fair value of these shares is included due to his mid-cycle hiring date.for each executive officer.

In setting each compensation component for our executive officers, the Compensation Committee considered the competitive market data, together with other relevant factors, including the individual performance and experience of each executive, retention issues, internal pay equity and consistency issues, the Company’s performance, expected future contributions of each executive, historical compensation levels, tenure, promotions, increased responsibilities and industry conditions. These and other factors may affect whether one or more of the compensation components for any of our executive officers fallsis set outside of the benchmark range. In addition, the total direct compensation, annual cash bonus and long-term incentive compensation for one or more of our executive officers could be above or below this target range depending on the amounts earned under the performance-based awards.

Consistent with our pay-for-performance philosophy, our executive compensation program is generally structured so that a significant amount of each of our named executive officers’ compensation is variable compensation and “at risk” for non-payment if we fail, or the executive fails, to meet performance targets.

Components of Fiscal 20172019 Compensation

Salary. Our Compensation Committee establishes salaries on an annual basis taking into account the guideline benchmark target, levels of responsibility, prior experience and breadth of knowledge, potentialtarget. In reviewing fiscal 2019 salaries for advancement, recent promotions, past performance, internal equity issues and external pay practices. In setting fiscal 2017 salary levels, theour named executive officers, our Compensation Committee reviewed advice from FWCits independent compensation consultant regarding market practices and considered Mr. Duda’s recommendations for officers other than himself.

The Compensation Committee also considered other relevant factors, including the individual performance, skills and experience of each executive, internal pay equity issues, executive retention, promotions, increased responsibilities, peer comparisons and the Company’s performance. After deliberation, the Compensation Committee decided toincreased Mr. Duda’s salary by 3% and Mr. Khoury’s salary by 10%. In establishing the new salaries for Messrs. Tsoumas, Brotherton and Shetty, the Compensation Committee also considered each officer’s recent promotion and significant increase the salary of each of Messrs. Duda, Khoury, Kill and Koman by 3.0%.in responsibilities. The Compensation Committee setincreased the salaries of our recently promoted named executive officers as follows: Mr. Hrudicka’s salary in connection with hiring him asTsoumas (promoted to Chief Financial Officer. The Compensation Committee maintainedOfficer), 63%; Mr. Glandon’s salary at the same level for fiscal 2017 as fiscal 2016.Brotherton (promoted to President of Grakon), 25%; and Mr. Shetty (promoted to President of Dabir Surfaces), 31%.

Annual Performance-Based Bonuses. In July 2016, ourOur Compensation Committee established fiscal 20172019 annual performance-based cash bonus opportunities for certain of our executive officers after considering the guideline benchmark target, the individual performance and experience of each executive, retention issues, internal pay equity and industry conditions. The Compensation Committee reviewed advice from FWCFW Cook regarding market practices and considered Mr. Duda’s recommendations for officers other than himself. In setting the performance measures, our Compensation Committee considered, among other matters, past performance, the fiscal 20172019 operating budget Methode’s strategic plan, product development matters and general economic conditions. For Mr. Duda, the target amount payable under the annual performance-based cash

21

bonus was set at 100% of base salary. For all other executive officers, the amount payable at target was set at 66% of base salary. The Compensation Committee determined that 70% of the target annual performance-based cash bonus for Messrs. Duda, Hrudicka, Khoury and Koman would be based on a Company pre-tax income measure (as adjusted for acquisitions(excluding costs and related expenses and divestitures and related gains/losses and expenses)earnings from the Grakon acquisition) and 30% would be based on salesnew business bookings or revenue objectives and/or individual management objectives. For Mr. Kill, 25% of the target annual performance-based cash bonus would be based on the Company pre-tax income measure and 75% would be based on performance measures related to our Dabir Surface medical device products described below. The maximum amount payable with respect to the Company pre-tax income measuremeasures and new business objectives was set at 200% of the amount payable at the target level of performance, in order to alignwhich aligns the awardopportunity with competitive practice among the peer group. Due to Mr. Koman’s retirement, he was entitled to a pro-rata payment of his annual bonus based on his retirement date and the performance achieved with respect to the measures described below. In connection with his hiring, Mr. Hrudicka was guaranteed a minimum bonus of $150,000 for fiscal 2017. The Compensation Committee did not provide for an annual performance-based bonus opportunity for Mr. Glandon for fiscal 2017.

Set forth below is an outline of the annual performance-based cash bonus awards for fiscal 20172019 performance, including the maximum bonus, the relevant performance measures and the bonus paid. As a result of Mr. Koman’s retirement, the amounts set forth below have been adjusted pro rata based on his September retirement date.

Executive
Target
Bonus
Performance Measures and Amounts Payable*
Bonus Earned
Donald W. Duda
$
759,719
 
(1) Achieve consolidated pre-tax income (excluding costs and earnings from the Grakon acquisition) of $124.0 million (threshold), $130.5 million (target) and $150.1 million (maximum), with $265,902, $531,803 and $1,063,606 payable at threshold, target and maximum, respectively. The Company achieved consolidated adjusted pre-tax income (excluding costs and earnings from the Grakon acquisition) below the threshold level of performance.
   
(2) Obtain certain new business bookings of $62.0 million (threshold), $65.0 million (target) and $75.0 million (maximum), with $113,958, $227,916 and $455,832 payable of threshold, target and maximum respectively. The Company booked $78.8 million for such new business and Mr. Duda earned $455,832.
   
$
455,832
 
Ronald L.G. Tsoumas
$
264,000
 
(1) Achieve consolidated pre-tax income (excluding costs and earnings from the Grakon acquisition) of $124.0 million (threshold), $130.5 million (target) and $150.1 million (maximum), with $92,400, $184,800 and $369,600 payable at threshold, target and maximum, respectively. The Company achieved consolidated adjusted pre-tax income (excluding costs and earnings from the Grakon acquisition) below the threshold level of performance.
   
(2) Update the Company’s Enterprise Risk Management program to the satisfaction of the Audit Committee ($39,600 payable). This performance measure was not achieved as of this time.
   
(3) Implement certain analytics reports for forecasting, account reconciliation and budget planning ($39,600 payable). This performance measure was achieved.
   
$
39,600
 

22

Executive
Target
Bonus
Performance Measures and Amounts Payable*
Bonus Earned
Joseph E. Khoury
$
294,756
 
(1) Achieve consolidated pre-tax income (excluding costs and earnings from the Grakon acquisition) of $124.0 million (threshold), $130.5 million (target) and $150.1 million (maximum), with $103,165, $206,329 and $412,658 payable at threshold, target and maximum, respectively. The Company achieved consolidated adjusted pre-tax income (excluding costs and earnings from the Grakon acquisition) below the threshold level of performance.
   
(2) Obtain certain new business bookings of $62.0 million (threshold), $65.0 million (target) and $75.0 million (maximum), with $44,214, $88,427 and $176,854 payable at threshold, target and maximum, respectively. The Company booked $78.8 million for such new business and Mr. Khoury earned $176,854.
   
$
176,854
 
Michael Brotherton
$
224,400
 
(1) Achieve consolidated pre-tax income (excluding costs and earnings from the Grakon acquisition) of $124.0 million (threshold), $130.5 million (target) and $150.1 million (maximum), with $78,540, $157,080 and $314,160 payable at threshold, target and maximum, respectively. The Company achieved consolidated adjusted pre-tax income (excluding costs and earnings from the Grakon acquisition) below the threshold level of performance.
   
(2) Achieve Grakon pre-tax income (excluding amortization and purchase accounting adjustments) of $24.8 million (threshold), $26.1 million (target) and $30.0 million (max), with $33,660, $67,320 and $134,640 payable at threshold, target and maximum, respectively. Grakon achieved adjusted pre-tax income (excluding amortization and purchase accounting adjustments) of $33.1 million and Mr. Brotherton earned $134,640.
   
$
134,640
 

23

Executive
Target
Bonus
Performance Measures and Amounts Payable*
Bonus Earned
Anil Shetty
$
245,520
 
(1) Achieve consolidated pre-tax income (excluding costs and earnings from the Grakon acquisition) of $124.0 million (threshold), $130.5 million (target) and $150.1 million (maximum), with $85,932, $171,864 and $343,728 payable at threshold, target and maximum, respectively. The Company achieved consolidated adjusted pre-tax income (excluding costs and earnings from the Grakon acquisition) below the threshold level of performance.
   
(2) Upgrade the Dabir Surfaces sales structure and salesforce to the satisfaction of the Chief Executive Officer ($36,828 payable). This performance measure was achieved.
   
(3) Expand Dabir Surfaces sales into new hospital customers (defined as being hospitals with different addresses from existing hospital customers) that are part of multi-institutional hospital networks, with 2 such hospitals at threshold, 5 such hospitals at target and 10 such hospitals at maximum, with $18,414, $36,828 and $73,656 payable at threshold, target and maximum, respectively. Dabir Surfaces achieved maximum performance and Mr. Shetty earned $73,656.
   
$
110,484
 
23 
*


Executive
Maximum BonusPerformance Measures and Amounts Payable*Bonus Earned

Donald W. Duda

 

$1,217,383

(1) Achieve consolidated pre-tax income (as adjusted for business acquisitions or dispositions) of $104.0 million (threshold), $109.5 million (target) and $125.9 million (maximum), with $250,638, $501,276 and $1,002,551 payable at threshold, target and maximum, respectively. The Company achieved consolidated pre-tax income of $117.3 million and Mr. Duda earned $740,709.

(2) Achieve $60.0 million in certain new business annual sales with a minimum established pre-tax margin ($214,832 payable). The Company achieved annual sales of $74.0 million for such new business.

$955,541
John R. Hrudicka$504,900

(1) Achieve consolidated pre-tax income (as adjusted for business acquisitions or dispositions) of $104.0 million (threshold), $109.5 million (target) and $125.9 million (maximum), with $103,950, $207,900 and $415,800 payable at threshold, target and maximum, respectively. The Company achieved consolidated pre-tax income of $117.3 million and Mr. Hrudicka earned $307,203.

(2) Implement changes to the ERP system related to foreign currency conversions ($89,100 payable). This performance measure was achieved.

$396,303
Joseph E. Khoury$408,020

(1) Achieve consolidated pre-tax income (as adjusted for business acquisitions or dispositions) of $104.0 million (threshold), $109.5 million (target) and $125.9 million (maximum), with $84,004, $168,008 and $336,016 payable at threshold, target and maximum, respectively. The Company achieved consolidated pre-tax income of $117.3 million and Mr. Khoury earned $248,257.

(2) Achieve $60.0 million in certain new business annual sales with a minimum established pre-tax margin ($72,004 payable). The Company achieved annual sales of $74.0 million for such new business.

$320,261
Theodore P. Kill$263,210

(1) Achieve consolidated pre-tax income (as adjusted for business acquisitions or dispositions) of $104.0 million (threshold), $109.5 million (target) and $125.9 million (maximum), with $26,321, $52,642 and $105,284 payable at threshold, target and maximum, respectively. The Company achieved consolidated pre-tax income of $117.3 million and Mr. Kill earned $77,786.

(2) Achieve $2.0 million in revenue from our Dabir Surface medical device products ($78,963 payable). This performance measure was not met.

(3) Obtain a reimbursement code for our Dabir Surface medical device products ($78,963 payable). This performance measure was not met due to the Company’s decision to defer acceptance of the reimbursement code until a later year. After reviewing the basis for this decision, the Compensation Committee determined that it would be appropriate to approve the payout for fiscal 2017 with the understanding that Mr. Kill would not be eligible to be rewarded for the same performance in the future.

$156,749
Douglas A. Koman$175,788

(1) Achieve consolidated pre-tax income (as adjusted for business acquisitions or dispositions) of $104.0 million (threshold), $109.5 million (target) and $125.9 million (maximum), with $36,250, $72,499 and $144,999 payable at threshold, target and maximum, respectively. The Company achieved consolidated pre-tax income of $117.3 million and Mr. Koman earned $107,137.

(2) Implement changes to the ERP system related to foreign currency conversions ($31,171 payable). This performance measure was achieved.

$138,307

*               Payouts are interpolated for performance falling between established performance objectives.

Prior to his promotion as executive officer in fiscal 2019, Mr. Brotherton participated in the Company’s new business bookings incentive plan for certain non-executive officers which provides for payments following the completed launch of certain new business programs. In fiscal 2019, Mr. Brotherton received a final payment of $50,000 under the new business bookings incentive plan.

Other Benefits and Perquisites. Our U.S.-based executive officers are eligible to participate in all of our employee benefit plans, such as medical, dental, vision, group life, disability and, as applicable, our 401(k) savings plan (with a company contribution equal to three percent (3%) of salary, subject to certain limitations), in each case,

24 

on the same basis as our other employees. Prior to their promotion as executive officers in fiscal 2019, Messrs. Brotherton and Shetty participated in a discretionary matching program for certain non-executive officers. The program awards a discretionary matching payment equal to the amount paid to the employee three years earlier, subject to the employee’s continued employment. In fiscal 2019, Messrs. Brotherton and Shetty received matching payments of $125,000 and $150,000, respectively, pursuant to the program. Messrs. Brotherton and Shetty are eligible to receive matching payments through fiscal 2021. Our U.S.-based executive officers are also provided deferred compensation opportunities through a non-qualified Deferred Compensation Plan. We have never contributed any amounts to the Deferred Compensation Plan on behalf of any of the named executive officers. For a description of the Deferred Compensation Plan, please see “Executive Compensation — Nonqualified Deferred Compensation,” below. In addition, a few perquisites are provided to the named executive officers. Perquisites include a company car allowance, professional association dues and provision for an annual physical exam.

Change of Control Arrangements. We have entered into change of control agreements with all of our named executive officers, other than Mr. Khoury, that provide certain benefits upon termination in connection with a change of control event, including Mr. Hrudicka upon his hiring in fiscal 2017.event. As a Lebanese resident, Mr. Khoury is entitled to certain payments in the event of his termination under the Lebanese Labor Laws. These change of control agreements are designed to promote stability and continuity of senior management if a change of control event were to occur, both of which are in the best interest of Methode and our shareholders. Our executives are not entitled to a gross-up payment for excise taxes under our change of control agreements. In addition, our change of control agreements are “double trigger” whereby the executives are

24

only entitled to a severance payment if an executive is terminated without cause or an executive terminates for good reason subsequent to a change of control. Our change of control provisions for the named executive officers are summarized below under “Executive Compensation − Potential Payments Upon Termination or Change of Control.”

Fiscal 2016 to 2020 Long-Term Incentive Program

During fiscal 2016, our Compensation Committee adopted a five-year, long-term incentive program consisting of a mix of 60% performance-based RSAs, at target performance, and 40% time-based RSUs (the “Fiscal 2016 LTI“LTI Program”). Mr. Hrudicka received an award under the Fiscal 2016 LTI Program in fiscal 2017. The number of RSAs earned will vary based on performance relative to established goals for threshold, target and maximum performance. Performance will be based on the Company’s earnings before net interest, taxes, fixed asset depreciation and intangible asset amortization (“EBITDA”) for fiscal 2020, subject to certain adjustments, including adjustments for certain acquisitions and divestitures. The RSUs are subject to a vesting period based on continued service, with no RSUs vesting prior to the end of fiscal 2018, subject to acceleration in certain limited circumstances. The Compensation Committee intends for the Fiscal 2016 LTI Program to cover all long-term equity incentive grants to the participants through fiscal 2020.

A key consideration of the Compensation Committee in developing the Fiscal 2016 LTI Program was the success of the prior five-year, long-term incentive program which concluded as of the end of fiscal 2015 (the “Fiscal 2011 LTI Program”). The Fiscal 2011 LTI Program included performance-based RSAs, performance-based tandem cash awards, RSUs and stock options. During the five-year period of the Fiscal 2011 LTI Program, revenues grew at an annualized rate of 18.5%, which supported annualized pre-tax profit growth and diluted earnings per share growth of 73.0% and 47.5%, respectively. In addition, we realized strong annualized total shareholder return of 34.0% during the period. During this period, our industry-leading performance reflected the introduction of numerous new products and technologies, the benefits of selective licensing and other business arrangements, the expansion of lower-cost manufacturing facilities and further vertical integration The Compensation Committee concluded that the Fiscal 2011 LTI Program succeeded in focusing our executive officers on growing the Company and appropriately rewarded our executive officers for creating value for our shareholders.

The Compensation Committee intends for the Fiscal 2016 LTI Program to continue creating value for our shareholders using a long-term program that aligns pay with performance and includes a strong retention feature. In structuring the Fiscal 2016 LTI Program, the Compensation Committee considered the advice of FWC,FW Cook, its independent executive compensation consultant, regarding market practices, award mix and size, possible performance criteria and alternative program structures. The Compensation Committee also considered Mr. Duda’s recommendations for officers other than himself.

The Compensation Committee considered multiple approaches for the Fiscal 2016 LTI program, including the use of annual grants and alternative performance periods. After careful review, the Compensation Committee determined that the five-year program is appropriate after considering the success of the Fiscal 2011 LTI Program discussed above, as well as the lengthy sales and product development cycles and significant upfront capital requirements for many of the Company’s products. The Compensation Committee believes the five-year term will focus our executive officers on the Company’s long-term objectives and retain our top executive talent over the period.

25 

The Fiscal 2016 LTI Program is comprised entirely of equity awards in order to directly align the interests of our executive officers with those of our shareholders. The Compensation Committee believes that the award mix of 60% performance-based RSAs, at target performance, and 40% time-vested RSUs supports the Company’s operating performance and retention objectives, respectively. Unlike the Fiscal 2011 LTI Program, stock options and performance-based tandem cash awards are not components of the Fiscal 2016 LTI Program, in part due to accounting considerations, including the high costs of stock options relative to historical grants. Instead, the Compensation Committee elected to place greater emphasis on the performance-based RSAs, which are subject to forfeiture if the performance goals are not met.

The Compensation Committee applied EBITDA, as adjusted, EBITDA as the RSA performance metric because it is one of the primary operating metrics tracked by the Company and its shareholders. The adjusted EBITDA performance goals set forth below align with the Company’s targeted 9% to 10% annual growth rate for EBITDA for the period. The adjustments to EBITDA for acquisitions and divestitures are designed to mitigate unintended windfalls to management for transactionscertain acquisitions and also to safeguard management from unintended penalties for shareholder-friendly transactionsdivestitures that negatively impact the fiscal 2020 performance results.

In general, the Compensation Committee targeted the Fiscal 2016 LTI Program awards in the 50th50th to 75th75th percentile range of competitive practice, which aligned with the Company’s relative positioning in terms of revenues, net income and market capitalization versus its peer group. In making these benchmarking determinations, the Compensation Committee assumed that each executive would achieve the target level of performance under the RSAs and included

25

one-fifth of the grant date fair value of these shares in these comparative calculations. For Mr. Hrudicka, one-fourth of the grant date fair value of these shares was included due to his mid-cycle hiring date. In determining the size of the award to each of our executive officers, the Compensation Committee also considered other relevant factors, including the individual performance and experience of each executive, internal pay equity and consistency issues, expected future contributions of each executive, historical compensation levels and tenure.

The table below sets forth the number of target RSAs and RSUs awarded to Messrs. Duda, Hrudicka, Khoury, Kill and Komanthe named executive officers (“Target Shares”). Mr. Glandon did not receive an award under the Fiscal 2016 LTI Program.


Executive
Number of Shares
Target RSAs*RSUs
Donald W. Duda180,000120,000
John R. Hrudicka48,00032,000
Joseph E. Khoury90,00060,000
Theodore P. Kill90,00060,000
Douglas A. Koman60,00040,000

* The number of shares earned will depend on performance and may be up to 150% of this number.

Executive
Number of Shares
Target RSAs*
RSUs
Donald W. Duda
 
180,000
 
 
120,000
 
Ronald L.G. Tsoumas
 
33,000
 
 
22,000
 
Joseph E. Khoury
 
90,000
 
 
60,000
 
Michael Brotherton
 
36,000
 
 
24,000
 
Anil Shetty
 
36,000
 
 
24,000
 
*The number of shares earned will depend on performance and may be up to 150% of this number.

Performance-Based RSAs. The number of RSAs earned will vary based on performance relative to established goals for threshold performance, target performance and maximum performance. The executive will not earn any shares if threshold performance is not met. Performance will be based on the Company’s EBITDA for fiscal 2020, subject to certain adjustments. All positive EBITDA from acquisitions that close during the term of the program and that are not accretive (as defined in the respective award agreement) in fiscal 2020 will be excluded. All positive EBITDA from acquisitions that close during fiscal 2019 or fiscal 2020 that are accretive in fiscal 2020 shall be included for purposes of determining fiscal 2020 EBITDA up to the target level and shall be excluded for purposes of determining fiscal 2020 EBITDA above the target level. For any divestitures approved by the Board during the period, the final four quarters of EBITDA from the divested business will be included in fiscal 2020 EBITDA. The performance measures and corresponding percentages of the target shares earned are set forth below.

Performance Measure
Fiscal 2020 EBITDA, As Adjusted EBITDA
Percentage of Target RSAs Earned*Earned*
Threshold Performance
$198.9 million
50%
50
%
Target Performance
$221.0 million
100%
100
%
Maximum Performance
$243.1 million
150%
150
%

* Payouts are interpolated for performance falling between established performance measures.

26 *Payouts are interpolated for performance falling between established performance measures.

Dividends will not be paid on the RSAs until the shares have been earned. At such time, the executive will be entitled to a dividend equivalent payment based on the dividends declared during the restricted period and the number of shares earned.

In the event of an executive’s death or disability, he or she will earn all of the Target Shares. In the event of an executive’s qualified retirement, the executive will be eligible to earn a prorated number of shares based on the number of months during the 60-month performance period that have elapsed prior to retirement and Methode’s actual fiscal 2020 adjusted EBITDA. In connection with Mr. Koman’s retirement, he is eligible to earn 28.3% of his Target Shares at target performance.EBITDA result. In the event of a change of control in which the successor company does not assume the RSAs, the executive will earn a prorated number of the Target Shares based on the number of months during the 60-month performance period that have elapsed prior to the change of control. If the successor company assumes the RSAs and, if the executive is terminated without cause or resigns for good reason within a period of time after the transaction (two years for Messrs.Mr. Duda and Hrudicka and one year for Messrs. Khoury and Kill)our other executive officers), then the executive will earn a prorated number of the Target Shares based on the number of months during the 60-month performance period that have elapsed prior to termination of employment. The Compensation Committee believes these provisions regarding the treatment of the RSAs in the event of death, disability, retirement or a change of control reflect fair and reasonable treatment under these scenarios based on current governance best practices and competitive standards.

Time-Based RSUs. The RSUs are subject to a vesting period based on continued service, with 30% vestingvested at the end of fiscal 2018 30% at the end ofand fiscal 2019, and 40% vesting at the end of fiscal 2020. Following vesting, the delivery of the stock underlying the RSUs will be deferred for Messrs. Duda, Tsoumas and Khoury until the earlier of the executive’s

26

termination of employment or a change of control. Dividend equivalents will not be paid on the RSUs until the units have vested. Following vesting and until the delivery of the underlying common stock, each executive will be entitled to a quarterly payment in an amount equal to the aggregate per share cash dividend paid during the quarter multiplied by the number of vested RSUs held by the executive.

In the event of an executive’s death or disability, all unvested RSUs will become immediately and fully vested. In the event of an executive’s qualified retirement, a prorated number of RSUs will vest based on the months during the 60-month vesting period that have elapsed prior to retirement. In connection with Mr. Koman’s retirement, 11,333 of his RSUs vested. In the event of a change of control in which the successor company does not assume the RSUs, all unvested RSUs will become immediately and fully vested. If the successor company assumes the RSUs and, if the executive is terminated without cause or resigns for good reason within a period of time after the transaction (two years for Messrs.Mr. Duda and Hrudicka and one year for Messrs. Khoury and Kill)our other executive officers), then all unvested RSUs will become immediately and fully vested. The Compensation Committee believes these provisions regarding the treatment of the RSUs in the event of death, disability, retirement or a change of control reflect fair and reasonable treatment under these scenarios based on current governance best practices and competitive standards.

Significant Policies and Procedures

Stock Ownership Policy. Our Compensation Committee considers stock ownership by management to be an important means of linking management’s interests with those of our shareholders. After considering the importance of stock ownership, our Compensation Committee maintains stock ownership guidelines for our executive officers. The requirements are subject to a phase-in period in the event of a new hire or a promotion. Our Chief Executive Officer is expected to own stock with a value at least equal to six (6) times his base salary, our Chief Operating Officer is expected to own stock with a value at least equal to three (3) times his base salary and all other executive officers are expected to own stock with a value at least equal to two (2) times their base salary. Vested and unvested time-based RSUs are included in the calculation of stock ownership for purposes of these guidelines. The value of each executive officer’s common stock holdings is determined as of the end of each fiscal year based on the average daily closing price of Methode’s common stock for such fiscal year. All of our named executive officers were in compliance with our stock ownership guidelines for fiscal 2017.2019, subject to the phase-in-period for new hires and promotions.

Insider Trading Policy. Our Insider Trading Policy prohibits our directors, executive officers and certain key employees from engaging in certain transactions involving our common stock, including options trading, short sales, derivative transactions and hedging transactions. In addition, these directors, executive officers and key employees are prohibited from holding our common stock in a margin account or otherwise pledging our common stock as collateral for a loan.

Policy With Respect to Deductibility of Compensation. Internal Revenue Code Section 162(m) generally limits the deductibility of the Code generally denies corporate tax deductions for annual compensation exceedingin excess of $1 million paid to certain employees (generallyour named executive officers. Under the

27 

chief executive officer tax rules in effect before 2018, compensation that qualified as “performance-based” was deductible without regard to this $1 million limit. In prior years, the awards of options, performance-based RSAs, and the three other most highly compensatedannual performance-based cash bonuses to our named executive officers were structured in order to qualify for this performance-based compensation exception. However, the 2017 Tax Cuts and Jobs Act (the “Tax Act”), eliminated this performance-based compensation exception effective January 1, 2018, subject to a special rule that “grandfathers” certain prior awards. As a result, compensation that the Compensation Committee structured in 2017 and prior years with the intent of a public company, but excluding the chief financial officer), unless that compensation qualifiesqualifying as performance-based compensation or otherwise being deductible under a shareholder approved planSection 162(m) that is paid on or after January 1, 2018 may not be fully deductible, depending on the application of the special grandfather rules. Moreover, from and meets certain other technical requirements. While it isafter January 1, 2018, compensation awarded in excess of $1 million to our named executive officers generally will not be deductible. Going forward, the general intention of our Compensation Committee will continue to maximize deductibility, our Compensation Committee seeksretain the flexibility to make decisionsdesign compensation programs that are in the best interestlong-term interests of Methodethe Company and itsour shareholders even if those decisions do not result in full deductibility under Section 162(m).after taking into account a variety of factors, including deductibility.

Clawback Policy. In the event we are required to restate our financial statements due to material noncompliance, our Incentive Compensation Recoupment Policy requires us to recover from our current or former executive officers certain amounts of incentive-based compensation paid within the prior three years.years that were erroneously paid.

27

COMPENSATION COMMITTEE REPORT

Our Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis with management and, based on such review and discussion, our Compensation Committee recommended to our Board of Directors that the Compensation Discussion and Analysis be included in this proxy statement.

COMPENSATION COMMITTEE
Martha Goldberg Aronson, Chair

Warren L. Batts

Brian J. Cadwallader
Darren M. Dawson

Isabelle C. Goossen
Christopher J. Hornung
Paul G. Shelton

28 

28

EXECUTIVE COMPENSATION

Summary Compensation Table

The following table sets forth certain summary information regarding the compensation awarded to, earned by or paid by us to, or for the account of, our Chief Executive Officer, our Chief Financial Officer our retired Chief Financial Officer and our three other most highly compensated executive officers (the “named executive officers”) for the threefour fiscal years ended April 29, 2017.27, 2019.

Name and

Principal Position

Fiscal

Year

Salary

($)

Bonus ($)(1)

Stock Awards

($) (2)

Option Awards

($) (2)

Non-Equity Incentive Plan

Compensation

($)

All Other
Compensation
($) (7)

Total

($)

    RSAs(3)RSUs(4) Tandem Cash (5)

Annual

Bonus (6)

  

Donald W. Duda

President and Chief Executive Officer

2017716,108----------955,541138,1691,809,818
2016695,588--6,080,4004,053,600----572,102311,11411,712,805
2015675,000115,000----599,6003,487,2001,147,500429,1306,453,430

John R. Hrudicka

Chief Financial Officer and
Vice President, Corporate Finance (8)

2017346,154--1,675,2001,116,800----396,30312,4813,546,938
          

Joseph E. Khoury

Senior Vice President (9)

2017362,518----------320,26114,482697,261
2016359,600--3,040,2002,026,800----184,12790,2215,700,948
2015352,32465,000----179,8801,046,160401,676107,3302,152,370
Theodore P. Kill, Vice President,
Worldwide Automotive Sales and
President of Dabir Surfaces
2017316,720----------156,74937,760511,229
2016310,034--2,704,5001,803,000----191,079113,8665,122,478
2015295,00065,000----179,8801,046,160230,100123,8801,940,020

Timothy R. Glandon

Vice President

2017295,000------------31,455326,455
2016295,000------------103,952398,952
2015295,00050,000----179,8801,046,160272,580119,0631,962,683

Douglas A. Koman

Retired Chief Financial Officer and

Vice President, Corporate Finance (8)

2017197,363----------138,30713,258348,928
2016365,855--2,026,8001,351,200----204,539223,8934,172,287
2015355,00090,000----239,8401,394,880362,165148,8172,590,702
          

Name and
Principal Position
Fiscal
Year
Salary
($)
Stock Awards
($)(1)
Non-Equity
Incentive Plan
Compensation
($)(4)
All Other
Compensation
($)(5)
Total
($)
RSAs(2)
RSUs(3)
Donald W. Duda
President and Chief
Executive Officer
 
2019
 
 
759,719
 
 
 
 
 
 
455,832
 
 
174,027
 
 
1,389,578
 
 
2018
 
 
736,476
 
 
 
 
 
 
660,991
 
 
148,159
 
 
1,545,626
 
 
2017
 
 
716,108
 
 
 
 
 
 
955,541
 
 
138,169
 
 
1,809,818
 
 
2016
 
 
695,588
 
 
6,080,400
 
 
4,053,600
 
 
572,102
 
 
311,114
 
 
11,712,804
 
Ronald L.G. Tsoumas
Chief Financial
Officer and
Vice President,
Corporate Finance
 
2019
 
 
420,749
 
 
 
 
 
 
39,600
 
 
28,682
 
 
489,031
 
 
2018
 
 
245,942
 
 
 
 
 
 
155,532
 
 
30,174
 
 
431,648
 
 
2017
 
 
238,703
 
 
 
 
 
 
210,425
 
 
27,017
 
 
476,145
 
 
2016
 
 
231,880
 
 
1,114,740
 
 
743,160
 
 
129,628
 
 
21,976
 
 
2,241,384
 
Joseph E. Khoury
Chief Operating
Officer(6)
 
2019
 
 
446,607
 
 
 
 
 
 
176,854
 
 
22,062
 
 
645,523
 
 
2018
 
 
400,025
 
 
 
 
 
 
280,340
 
 
15,682
 
 
696,047
 
 
2017
 
 
362,518
 
 
 
 
 
 
320,261
 
 
14,482
 
 
697,261
 
 
2016
 
 
359,600
 
 
3,040,200
 
 
2,026,800
 
 
184,127
 
 
90,221
 
 
5,700,948
 
Michael Brotherton
Vice President and
President of Grakon(7)
 
2019
 
 
309,996
 
 
 
 
 
 
184,640
 
 
167,549
 
 
662,185
 
Anil Shetty
Vice President and
President Dabir
Surfaces(7)
 
2019
 
 
372,000
 
 
 
 
 
 
110,484
 
 
170,014
 
 
652,498
 
(1)Reflects discretionary cash bonuses awarded in early fiscal 2015 by the Compensation Committee in light of the Company’s strong fiscal 2014 performance.
(2)(1)Reflects the fair value at the date of grant. The value is calculated in accordance with Accounting Standards Codification Topic 718, Stock Compensation (“ASC 718”). Details of the assumptions used in valuing the awards are set forth in Note 4 to our audited financial statements included in our Annual Report on Form 10-K for such fiscal year.
(3)(2)These performance-based RSAs are eligible for vesting based on fiscal 2020 EBITDA, as adjusted, relative to established goals for threshold, target and maximum performance. At the time of the grants, we deemed achievement of target performance probable, and therefore the grant date fair values reflected above were calculated on that basis. If, instead, the RSA amounts had been calculated assuming the Company would achieve maximum performance, the grant date fair values for these RSAs would have been as follows: Mr. Duda, $9,120,600; Mr. Hrudicka, $2,512,800;Tsoumas $1,672,110; and Mr. Khoury, $4,560,300; Mr. Kill, $4,056,750 and Mr. Koman, $3,040,200.$4,560,300.
(4)(3)These RSUs are subject to a vesting period based on continued service, with 30% vestingvested at the end of fiscal 2018 30% vesting at the end ofand fiscal 2019 and 40% vesting at the end of fiscal 2020. TheFor Messrs. Duda, Tsoumas and Khoury, the RSUs are not eligible to be converted into common stock until a change of control or the executive officer leaves Methode.the Company.
(5)Reflects amounts paid under the performance-based Tandem Cash Awards under the Fiscal 2011 LTI Program.
(6)(4)Amounts reflect annual performance-based cash bonuses. For Mr. Brotherton, also includes a payment of $50,000 pursuant to the Company’s new business bookings incentive plan for non-executive officers.

29

(7)(5)Amounts included in All Other Compensation reflect the following for fiscal 2017:2019:

Executive

Vested

RSU Dividend Equivalents ($)

401(k) Contribution ($)

Life Insurance

($)

Car Allowance ($)Executive Physical ($)Gift Card ($)
Mr. Duda112,8267,9503,5649,6004,17950
Mr. Hrudicka07,95042804,05350
Mr. Khoury10,8000003,6820
Mr. Kill10,8007,9503,04812,0003,91250
Mr. Glandon10,8007,9505528,4003,75350
Mr. Koman3,6004,3101,3484,00000

Executive
Vested
RSU Dividend
Equivalents ($)
401(k)
Contribution
($)
Life
Insurance
($)
Car
Allowance ($)
Executive
Physical ($)
Mr. Duda
 
145,664
 
 
8,467
 
 
3,564
 
 
9,600
 
 
6,732
 
Mr. Tsoumas
 
11,704
 
 
9,949
 
 
1,029
 
 
6,000
 
 
0
 
Mr. Khoury
 
21,120
 
 
0
 
 
0
 
 
0
 
 
942
 
Mr. Brotherton
 
0
 
 
9,112
 
 
804
 
 
7,650
 
 
0
 
Mr. Shetty
 
0
 
 
8,634
 
 
580
 
 
10,800
 
 
0
 
29 

For Mr. Brotherton, also includes the following: (i) a monthly housing allowance of $7,500 and a monthly living allowance of $2,500 in connection with his relocation to Seattle; and (ii) a discretionary matching payment of $125,000 pursuant to the Company’s discretionary matching program for non-executive officers. For Mr. Shetty, also includes a matching payment of $150,000 pursuant to the Company’s discretionary matching program for non-executive officers.

In addition, for Mr. Koman, includes payments of $5,417 pursuant to the Consulting Agreement described in footnote (8) below.
(8)(6)Effective as of July 25, 2016, Mr. Koman resigned as Chief Financial Officer and Mr. Hrudicka was hired and appointed to such office.  Mr. Koman retired as an employee of the Company on September 15, 2016.  On September 16, 2016, the Company and Mr. Koman entered into a Consulting Agreement pursuant to which Mr. Koman agreed to provide consulting services to the Company and was paid $250 per hour for such services.  This Consulting Agreement terminated on July 28, 2017.
(9)

Mr. Khoury is a Lebanese resident and we paid Mr. Khoury’s cash compensation in Euros. For purposes of the Summary Compensation Table, this cash compensation was converted from Euros to U.S. Dollars using the average exchange rate of 1.3048 for fiscal 2015; 1.1085 for fiscal 2016; and 1.0926 for fiscal 2017.

2017, 1.1805 for fiscal 2018 and 1.1498 for fiscal 2019.
(7)Messrs. Brotherton and Shetty were appointed executive officers in September 2018.

Grants of Plan-Based Awards

The following table sets forth certain information regarding grants of plan-based non-equity incentive awards to the named executive officers during the fiscal year ended April 29, 2017.27, 2019.

Name

Grant

Date

Estimated Future Payouts Under

Non-Equity Incentive Plan Awards(1)

Estimated Future Payouts Under Equity Incentive Plan Awards(2)All Other Stock Awards: Number of Shares of Stock or Units(3)

Grant

Date Fair Value of Stock and Option Awards

($) (4)

Threshold

($)

Target

($)

Maximum

($)

Threshold (#)Target (#)Maximum (#)
Donald W. Duda7/12/2016465,470716,1081,217,383----------
         
John R. Hrudicka7/25/2016193,050297,000504,90024,00048,00072,00032,0002,792,000
         
Joseph E. Khoury7/12/2016156,008240,012408,020----------
         
Theodore P. Kill7/12/2016184,247210,568263,210----------
         
Timothy R. Glandon7/12/2016----------------
         
Douglas A.7/12/201667,376103,653175,788----------
Koman         

 
 
Estimated Future Payouts Under
Non-Equity Incentive Plan Awards(1)
Name
Grant
Date
Threshold
($)
Target
($)
Maximum
($)
Donald W. Duda
7/31/2018
 
379,860
 
 
759,719
 
 
1,519,438
 
Ronald L.G. Tsoumas
7/31/2018
 
171,600
 
 
264,000
 
 
448,800
 
Joseph E. Khoury
7/31/2018
 
147,379
 
 
294,756
 
 
589,512
 
Michael Brotherton
9/12/2018
 
112,200
 
 
224,400
 
 
448,800
 
Anil Shetty
7/31/2018
 
159,588
 
 
245,520
 
 
417,384
 
(1)(1)Reflects annual performance-based cash bonus awards pursuant to the Methode Electronics, Inc. 2014 Omnibus Incentive Plan (the “2014 Plan”). The executive officers’ bonus amounts are based on achieving certain performance measures. For purposes of this table, for any award components that include only one level of performance, we have included such amount in each of the threshold, target and maximum columns. For Mr. Koman, the amounts set forth above have been adjusted pro rata based on his retirement date.  Amounts earned in fiscal 20172019 by the executive officers under this award are reported in “Compensation Discussion and Analysis” and in the column titled “Non-Equity Incentive Plan Compensation-Annual Bonus” in the “Summary Compensation Table.” Details regarding these awards, including the relevant performance measures, are set forth in “Compensation Discussion and Analysis.”
(2)Reflects restricted stock awards granted pursuant to the 2014 Plan which are eligible for vesting based on the achievement of certain financial targets for fiscal 2020 EBITDA.  The unvested restricted stock awards are not entitled to payment of dividends, provided that at the time the shares vest, the executive is entitled to a payment based on the dividends declared during the restricted period and the number of shares earned.
(3)Reflects restricted stock units granted pursuant to the 2014 Plan.  These restricted stock units vest 30% on each of April 28, 2018 and April 27, 2019 and 40% on May 2, 2020, provided that the named executive officer remains a Methode employee.  The unvested restricted stock units are not entitled to payment of dividends until they vest.  The restricted stock units are not eligible to be converted into common stock until a change in control or the executive officer leaves Methode.
(4)Amounts represent the fair value as of the date of grant calculated in accordance with ASC 718.  Details of the assumptions used in valuing these options are set forth in Note 4 to our audited financial statements included in our Annual Report on Form 10-K for the fiscal year ended April 29, 2017.

30 

Alternative Summary Compensation Table

As discussed in “Compensation Discussion and Analysis-Fiscal 2016 to 2020 Long-Term Incentive Program,” in fiscal 2016, our Compensation Committee adopted a five-year, long-term equity incentive program consisting of a mix of 60% performance-based RSAs, at target performance, and 40% time-based RSUs (the “Fiscal 2016 LTI“LTI Program”). Mr. Hrudicka received an award under the Fiscal 2016 LTI Program in fiscal 2017. The number of RSAs earned will vary based on performance relative to established goals for threshold, target and maximum performance. Performance will be based on the Company’s earnings before net interest, taxes, fixed asset depreciation and intangible asset amortization (“EBITDA”) for fiscal 2020, subject to certain adjustments for acquisitions and divestitures. The RSUs are subject to vesting based on continued service, with no RSUs vesting prior to the end of fiscal 2018, subject to acceleration in certain limited circumstances. The Compensation Committee intends for the Fiscal 2016 LTI Program to cover all long-term equity incentive grants to the participants through fiscal 2020.

A key consideration of the Compensation Committee in developing the Fiscal 2016 LTI Program was the success of the prior five-year, long-term incentive program adopted in fiscal 2011 (the “Fiscal 2011 LTI Program”). The Fiscal 2011 LTI Program included performance-based RSAs, performance-based tandem cash awards, RSUs and stock options. The vesting of the performance-based RSAs and tandem cash awards were based on the achievement of internal enterprise value hurdles at the end of fiscal 2015. The time-based RSUs vested annually through fiscal 2015. Stock options were granted annually from fiscal 2011 through fiscal 2015.

Under the SEC’s proxy statement disclosure rules, the grant date fair value of the number of RSAs eligible for vesting at the target level of performance and the total number of RSUs awarded under the Fiscal 2016 LTI Program has been reported in the Summary Compensation Table above in fiscal 2016 for Messrs. Duda, Khoury, Kill and Koman and in fiscal 2017 for Mr. Hrudicka. The amounts earned pursuant to the performance-based tandem cash awards under the Fiscal 2011 LTI Program have been reported in the Summary Compensation Table above in fiscal 2015.2016.

The Company is presenting the following Alternative Summary Compensation Table in order to illustrate how the Compensation Committee views annualized total compensation under the Fiscal 2016 LTI Program and the Fiscal 2011 LTI Program. The Compensation Committee believes that due to the front-loaded nature of the RSA and RSU awards, and the reporting of the total tandem cash award values in fiscal 2015, the compensation amounts

30

disclosed in the Summary Compensation Table for our named executive officers other than Mr. Hrudicka overstate compensation attributable to fiscals 2015 andfiscal 2016 and understate compensation attributable to fiscal 2017. For Mr. Hrudicka, the Compensation Committee believes that the compensation amounts disclosed in the Summary Compensation Table overstate his2017, fiscal 2017 compensation.2018 and fiscal 2019.

The values in this table differ from the values disclosed in the Summary Compensation Table on page 29 of this proxy statement in that the value of the RSAs and the RSUs have been annualized equally over the respective five-year periods of the programs. For Mr. Hrudicka, the value of the grants has been annualized over four years due to his mid-cycle hiring date. In addition, the amounts earned under the tandem cash awards and reported entirely as fiscal 2015 compensation in the Summary Compensation Table have been annualized, with one-fifth of the value reported in fiscal 2015. In both the Summary Compensation Table and the Alternative Summary Compensation Table, the values for the RSA and RSU awards reflect grant date fair values calculated in accordance with the applicable accounting rules. The Alternative Summary Compensation Table below has been revised as described and does not comply with SEC rules for the Summary Compensation Table. Shareholders should not view this alternative table as a substitute for the Summary Compensation Table on page 30 and should review this Alternative Summary Compensation Table together with the Summary Compensation Table and other compensation tables contained herein that have been prepared in accordance with SEC rules.

31 

Alternative Summary Compensation Table

Name and

Principal Position

Fiscal

Year

 

 

Salary ($)

Bonus ($) (1)

Annualized Value of

Stock Awards ($)(2)

 

Option Awards ($)(3)

Non-Equity Incentive Plan Compensation ($)All Other Compensation ($)(10)Total ($)
    RSAsRSUs Annualized Value of Tandem Cash (8)

Annual

Bonus (9)

  

Donald W. Duda

President and Chief Executive Officer

2017716,108--1,216,080(4)810,720(5)----948,700138,1693,836,618

2016

2015

695,598

675,000

--

115,000

1,216,080(4)

388,000(6)

810,720(5)

194,000(7)

--

599,600

--

697,440

572,102

1,147,500

311,114

429,130

3,605,614

4,245,670

John R. Hrudicka

Chief Financial Officer and Vice President, Corporate Finance (11)

2017346,154--418,800(4)279,200(5)----396,30312,4811,452,938
          
          
          

Joseph E. Khoury

Senior Vice President (12)

2017362,518--608,040(4)405,360(5)----320,26114,4821,710,661

2016

2015

359,600

352,324

--

65,000

608,040(4)

116,400(6)

405,360(5)

58,200(7)

--

179,880

--

209,232

184,127

401,676

90,221

107,330

1,647,348

1,490,042

Theodore P. Kill

Vice President, Worldwide Automotive Sales and President of Dabir Surfaces

2017316,720--540,900(4)360,600(5)----156,74937,7601,412,279
2016310,034--540,900(4360,600(5)----191,079113,8661,516,479
2015295,00065,000116,400(6)58,200(7)179,880209,232230,100123,8801,277,692

Timothy R. Glandon

Vice President

2017295,000------------31,455326,455

2016

2015

295,000

295,000

--

50,000

--

116,400(6)

--

58,200(7)

--

179,880

--

209,232

--

272,580

103,952

119,063

398,952

1,300,355

Douglas A. Koman

Retired Chief Financial Officer and

Vice President, Corporate Finance (11)

2017197,363--405,360(4)270,240(5)----138,30713,2581,024,528
2016365,855--405,360(4)270,240(5)----204,539223,8931,469,887
2015355,00090,000155,200(6)77,600(7)239,840278,976362,165148,8171,707,598
          
    
 (1)Reflects discretionary cash bonuses awarded in early fiscal 2015 by the Compensation Committee in light of the Company’s strong fiscal 2014 performance. 
 (2)Reflects the annualized fair value at the date of grant.  See footnotes (2), (3) and (4) of the Summary Compensation Table for additional information. 
 (3)Reflects the fair value at the date of grant.  See footnote (2) to the Summary Compensation Table for additional information. 
 (4)These performance-based RSAs are eligible for vesting based on fiscal 2020 EBITDA relative to established goals for threshold, target and maximum performance.  The grant date fair values reflected above were calculated assuming the achievement of the target level of performance. 
 (5)These RSUs are subject to vesting based on continued service, with 30% vesting at the end of fiscal 2018, 30% vesting at the end of fiscal 2019 and 40% vesting at the end of fiscal 2020.  The RSUs are not eligible to be converted into common stock until a change of control or the executive officer leaves Methode. 
 (6)These performance-based RSAs vested based on fiscal 2015 internal enterprise value relative to established goals for threshold and target performance.    
 (7)These RSUs vested 20% each year on the last day of Methode’s fiscal year from fiscal 2011 through fiscal 2015.  The vested RSUs are not eligible to be converted into common stock until a change of control or the executive officer leaves Methode. 
 (8)Reflects the annualized amounts paid under the performance-based tandem cash awards under the Fiscal 2011 LTI Program.   
 (9)Amounts reflect annual performance-based cash bonuses. 
 (10)See footnote (7) of the Summary Compensation Table for information regarding the amounts included in All Other Compensation. 
 (11)See footnote (8) of the Summary Compensation Table for information regarding the hiring of Mr. Hrudicka and Mr. Koman’s retirement. 
 (12)Mr. Khoury is a Lebanese resident and we paid Mr. Khoury’s cash compensation in Euros.   For purposes of the Alternative Summary Compensation Table, this cash compensation was converted from Euros to U.S. Dollars.  See footnote (9) of the Summary Compensation Table for information regarding the exchange rates. 
                 
Name and
Principal Position
Fiscal
Year
Salary ($)
Annualized Value of
Stock Awards ($)(1)
Non-Equity
Incentive Plan
Compensation
($)(4)
All Other
Compensation
($)(5)
Total ($)
RSAs(2)
RSUs(3)
Donald W. Duda
President and Chief Executive Officer
 
2019
 
 
759,719
 
 
1,216,080
 
 
810,720
 
 
455,832
 
 
174,027
 
 
3,416,378
 
 
2018
 
 
736,476
 
 
1,216,080
 
 
810,720
 
 
660,991
 
 
148,159
 
 
3,572,426
 
 
2017
 
 
716,108
 
 
1,216,080
 
 
810,720
 
 
948,700
 
 
138,169
 
 
3,829,777
 
 
2016
 
 
695,598
 
 
1,216,080
 
 
810,720
 
 
572,102
 
 
311,114
 
 
3,605,614
 
Ronald L.G. Tsoumas
Chief Financial
Officer and
Vice President,
Corporate Finance
 
2019
 
 
420,749
 
 
222,948
 
 
148,632
 
 
39,600
 
 
28,682
 
 
860,611
 
 
2018
 
 
245,942
 
 
222,948
 
 
148,632
 
 
155,532
 
 
30,174
 
 
803,228
 
 
2017
 
 
238,703
 
 
222,948
 
 
148,632
 
 
210,425
 
 
27,017
 
 
847,725
 
 
2016
 
 
231,880
 
 
222,948
 
 
148,632
 
 
129,628
 
 
21,976
 
 
755,064
 
Joseph E. Khoury
Chief Operating
Officer(6)
 
2019
 
 
446,607
 
 
608,040
 
 
405,360
 
 
176,854
 
 
22,062
 
 
1,658,923
 
 
2018
 
 
400,025
 
 
608,040
 
 
405,360
 
 
280,340
 
 
15,682
 
 
1,717,170
 
 
2017
 
 
362,518
 
 
608,040
 
 
405,360
 
 
320,261
 
 
14,482
 
 
1,710,661
 
 
2016
 
 
359,600
 
 
608,040
 
 
405,360
 
 
184,127
 
 
90,221
 
 
1,647,348
 
Michael Brotherton
Vice President and President Grakon(7)
 
2019
 
 
309,996
 
 
243,216
 
 
162,144
 
 
184,640
 
 
167,549
 
 
1,067,545
 
Anil Shetty
Vice President and President Dabir Surfaces(7)
 
2019
 
 
372,000
 
 
243,216
 
 
162,144
 
 
110,484
 
 
170,014
 
 
1,057,858
 
32 (1)Reflects the annualized fair value at the date of grant. See footnotes (1), (2) and (3) of the Summary Compensation Table for additional information.
(2)These performance-based RSAs are eligible for vesting based on fiscal 2020 EBITDA, as adjusted, relative to established goals for threshold, target and maximum performance. The grant date fair values reflected above were calculated assuming the achievement of the target level of performance.
(3)These RSUs are subject to vesting based on continued service, with 30% vested at the end of fiscal 2018 and fiscal 2019 and 40% vesting at the end of fiscal 2020. For Messrs. Duda, Tsoumas and Khoury, the RSUs are not eligible to be converted into common stock until a change of control or the executive officer leaves Methode.
(4)Amounts reflect annual performance-based cash bonuses.
(5)See footnote (5) of the Summary Compensation Table for information regarding the amounts included in All Other Compensation.
(6)Mr. Khoury is a Lebanese resident and we paid Mr. Khoury’s cash compensation in Euros. For purposes of the Alternative Summary Compensation Table, this cash compensation was converted from Euros to U.S. Dollars. See footnote (7) of the Summary Compensation Table for information regarding the exchange rates.
(7)Messrs. Brotherton and Shetty were appointed executive officers in September 2018.

31

Outstanding Equity Awards at Fiscal Year-End

The following table sets forth certain information regarding the outstanding equity awards of the named executive officers at April 29, 2017.27, 2019.  

NameOption AwardsStock Awards

Number of Securities Underlying Unexercised Options

(#)

Exercisable

Number of Securities Underlying Unexercised Options

(#)

Unexercisable

Option Exercise Price

($)

Option Expiration DateNumber of Shares or Units of Stock That Have Not Vested (#)(2)Market Value of Share of Units of Stock That Have Not Vested ($)(3)Equity Incentive Plan Awards: Numbers of Unearned Shares, Units or Other Rights That Have Not Yet Vested (#)(4)Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Yet Vested ($)(3)
Donald W. Duda26,66713,333(1)37.017/7/2024120,0005,346,000270,00012,028,500
John R. Hrudicka---- ----32,0001,425,60072,0003,207,600
Joseph E. Khoury8,0004,000(1)37.017/7/202460,0002,673,000135,0006,014,250
Theodore P. Kill---- ----60,0002,673,000135,0006,014,250
Timothy R. Glandon8,0004,000(1)37.017/7/2024--------
Douglas A. Koman---- --------25,4991,135,980

Name
Option Awards
Stock Awards
Number of
Securities
Underlying
Unexercised
Options
(#)
Exercisable(1)
Number of
Securities
Underlying
Unexercised
Options
(#)
Unexercisable
Option
Exercise
Price
($)
Option
Expiration
Date
Number of
Shares or
Units of
Stock That
Have Not
Vested
(#)(2)
Market
Value of
Share of
Units of
Stock That
Have Not
Vested ($)(3)
Equity
Incentive Plan
Awards:
Numbers of
Unearned
Shares, Units
or Other
Rights That
Have Not Yet
Vested (#)(4)
Equity
Incentive
Plan
Awards:
Market or
Payout
Value of
Unearned
Shares,
Units or
Other
Rights That
Have Not
Yet Vested
($)(3)
Donald W. Duda
 
40,000
 
 
 
 
37.01
 
 
7/7/2024
 
 
48,000
 
 
1,407,840
 
 
180,000
 
 
5,279,400
 
Ronald L.G. Tsoumas
 
8,000
 
 
 
 
37.01
 
 
7/7/2024
 
 
8,800
 
 
258,104
 
 
33,000
 
 
967,890
 
Joseph E. Khoury
 
12,000
 
 
 
 
37.01
 
 
7/7/2024
 
 
24,000
 
 
703,920
 
 
90,000
 
 
2,639,700
 
Michael Brotherton
 
1,668
 
 
 
 
37.01
 
 
7/7/2024
 
 
9,600
 
 
281,568
 
 
36,000
 
 
1,055,880
 
Anil Shetty
 
5,000
 
 
 
 
37.01
 
 
7/7/2024
 
 
9,600
 
 
281,568
 
 
36,000
 
 
1,055,880
 
(1)These options were granted in July 7, 2014. One-third of these options vestvested on each of the first, second and third anniversaries of the grant date.
(2)These RSUs are subject to vesting based on continued service with 30% vesting at the end of fiscal 2018, 30% vesting at the end of fiscal 2019 and 40% vesting atthrough the end of fiscal 2020.
(3)Calculated based on the closing price of the Company’s common stock on April 28, 201726, 2019 of $44.55$29.33 per share.
(4)These performance-based restricted stock awards are eligible for vesting based on the achievement of certain financial targets for fiscal 2020 EBITDA.EBITDA, as adjusted. Reflects the number of shares to be earned if the target level of performance is achieved.

Option Exercises and Stock Vested

The following table sets forth certain information regarding option exercises by the named executive officers and the vesting of restricted stock units during fiscal 2017.2019.

NameOption AwardsStock Awards
Number of Shares Acquired on Exercise (#)

Value Realized on Exercise

($) (1)

Number of Shares Acquired on Vesting (#) (2)

Value Realized on Vesting

($) (3)

Donald W. Duda40,000841,938----
John R. Hrudicka--------
Joseph E. Khoury16,000429,609----
Theodore P. Kill12,000226,452----
Timothy R. Glandon12,000236,381----
Douglas A. Koman42,666615,23011,333393,255

Name
Option Awards
Stock Awards
Number of Shares
Acquired on Exercise (#)
Value Realized on
Exercise ($)(1)
Number of Shares
Acquired on Vesting (#)(2)
Value Realized on
Vesting ($)(3)
Donald W. Duda
 
 
 
 
 
36,000
 
 
1,055,880
 
Ronald L.G. Tsoumas
 
 
 
 
 
6,600
 
 
193,578
 
Joseph E. Khoury
 
 
 
 
 
18,000
 
 
527,940
 
Michael Brotherton
 
 
 
 
 
7,200
 
 
211,176
 
Anil Shetty
 
 
 
 
 
7,200
 
 
211,176
 
(1)(1)Calculated based on market value of Methode’s common stock at the time of exercise, minus the exercise cost.
(2)(2)Reflects RSUs awarded pursuant to our Fiscal 2016 LTI Program.  These sharesProgram that vested in connection with Mr. Koman’s retirement in September 2016.on April 27, 2019. For Messrs. Duda, Tsoumas and Khoury, the RSUs are not eligible to be converted into common stock until a change of control or the executive leaves the Company.
(3)(3)Calculated based on the closing price of Methode’s common stock on September 15, 2016April 26, 2019 of $34.70$29.33 per share.

33 

32

Nonqualified Deferred Compensation

The following table sets forth certain information regarding deferred compensation with respect to the named executive officers for fiscal 2017.2019.

Name

Executive Contributions in Last Fiscal Year

($) (1)

Registrant Contributions in Last Fiscal Year

($)

Aggregate Earnings in Last

Fiscal Year

($)

Aggregate Withdrawals/ Distributions

($) (2)

Aggregate Balance at Last Fiscal Year-End

($)

 
Donald W. Duda0090031,071 
John R. Hrudicka00000 
Joseph E. Khoury00000 
Theodore P. Kill29,4500143,87401,203,393 
Timothy R. Glandon0060,473(122,408)423,416 
Douglas A. Koman00255,479(143,295)1,431,539 
 (1) All executive contributions were reported as compensation in the “Summary Compensation Table” under the “Salary” and/or “Non-Equity Incentive Plan Compensation” columns, depending on the source of the executive contribution.
 (2) Reflects distributions in accordance with the terms of each executive’s deferral election.
          

Name
Executive
Contributions
in Last Fiscal Year
($)(1)
Registrant
Contributions in
Last Fiscal Year
($)
Aggregate Earnings
in Last
Fiscal Year
($)
Aggregate
Withdrawals/
Distributions
($)(2)
Aggregate Balance
at Last Fiscal
Year-End
($)
Donald W. Duda
 
0
 
 
0
 
 
610
 
 
0
 
 
31,973
 
Ronald L.G. Tsoumas
 
33,847
 
 
0
 
 
24,198
 
 
0
 
 
1,162,631
 
Joseph E. Khoury
 
0
 
 
0
 
 
0
 
 
0
 
 
0
 
Michael Brotherton
 
20,000
 
 
0
 
 
4,263
 
 
0
 
 
85,837
 
Anil Shetty
 
16,000
 
 
0
 
 
733
 
 
0
 
 
16,733
 
(1)All executive contributions were reported as compensation in the “Summary Compensation Table” under the “Salary” and/or “Non-Equity Incentive Plan Compensation” columns, depending on the source of the executive contribution.
(2)Reflects distributions in accordance with the terms of each executive’s deferral election.

The Methode Electronics, Inc. Nonqualified Deferred Compensation Plan (the “Deferred Compensation Plan”) allows a select group of management and highly compensated employees to defer up to 75% of their annual base salary, 100% of their annual bonus, and/or 100% of their tandem cash award, if applicable, with an aggregate minimum deferral of $3,000. The minimum period of deferral is three years. Participants are immediately 100% vested.

In addition to employee-directed deferrals, we may make contributions to the Deferred Compensation Plan to make up for limits applicable under our qualified plans and may make additional discretionary contributions as well. Participants vest in company contributions in accordance with the schedule set forth in the applicable agreement or plan governing such contributions. We made no contributions to the Deferred Compensation Plan in fiscal 2017.2019.

Participants may elect from a list of certain mutual funds to determine any amounts credited or debited from their accounts, although we are under no obligation to invest the deferred amounts in any specified fund. This list is made available to all participants and account balances are credited or debited based on the current market rates for these funds. Participants may reallocate account balances and/or future deferrals on a daily basis.

Participants are entitled to receive a distribution from their account balances at the earlier of the end of the elected deferral period or retirement, disability, termination of employment or a change of control. Accounts are distributed in a lump sum or, in certain circumstances, in installments over a period of up to 15 years. Participants can also petition the Compensation Committee to receive a full or partial payout from the Deferred Compensation Plan in the event of an unforeseeable financial emergency.

34 

33

Potential Payments Upon Termination or a Change of Control

In the event our named executive officers are terminated or Methode undergoes a change of control, our named executive officers are entitled to certain payments under their change of control agreements, our stock plans and certain other benefit plans.

The following table summarizes payments payable to our named executive officers upon a change in control or the executive’s death, disability or qualified retirement under our outstanding equity and cash bonus awards.

Type of Award
Termination Scenario
Change in Control
Death or Disability

Qualified Retirement(1)

Retirement
(1)
Annual Performance-Based Cash Bonus
If the successor company does not assume the award, or if the successor company assumes the award and the executive is terminated without cause or resigns for good reason prior to payment, the executive will be entitled to the bonus payable assuming achievement of the target level of performance.
Entitled to the bonus payable assuming achievement of the target level of performance.
Eligible to earn a prorated bonus based on the number of months elapsed since the start of the fiscal year and the actual performance achieved as of the end of such fiscal year.
Restricted Stock Units
If the successor company does not assume the RSUs, or if the successor company assumes the RSUs and the executive is terminated without cause or resigns for good reason within a period of time after the transaction (two years for Messrs.Mr. Duda and Hrudicka and one year for Messrs. Khoury and Kill)the other executive officers), all unvested RSUs will become immediately and fully vested.
All unvested RSUs will become immediately and fully vested.
A prorated number of RSUs will vest based on the months elapsed since May 3, 2015.
Restricted Stock Awards

If the successor company does not assume the RSAs, or if the successor company assumes the RSAs and the executive is terminated without cause or resigns for good reason within a period of time after the transaction (two years for Messrs.Mr. Duda and Hrudicka and one year for Messrs. Khoury and Kill)the other executive officers), the executive will earn a prorated number of the RSAs eligible for vesting assuming the achievement of the target level of performance based on the number of months elapsed since May 3, 2015.



In either case, the executive is also entitled to a payment based on the dividends declared during the restricted period and the number of shares vested.

The number of RSAs eligible for vesting assuming the achievement of the target level of performance will become immediately and fully vested.



The executive is also entitled to a payment based on the dividends declared during the restricted period and the number of shares vested.

Eligible to earn a prorated number of shares based on the number of months elapsed since May 3, 2015 and Methode’s fiscal 2020 adjusted EBITDA.

EBITDA, as adjusted.

The executive is also entitled to a payment based on the dividends declared during the restricted period and the number of shares vested.

Stock OptionsImmediate vesting of outstanding option awards.Immediate vesting of all outstanding option awards.Immediate vesting of all outstanding option awards.

(1)(1)An executive’s qualified retirement occurs at or after age 65, or after age 55 with ourCompany consent.

35 

34

Messrs. Duda, Hrudicka, Kill and GlandonAll of our executive officers other than Mr. Khoury are parties to change of control agreements with the Company. Mr. Khoury is not a party to a change of control agreement. Pursuant to these change of control agreements, if within two years of a change of control or during a period pending a change of control, we terminate the executive’s employment without good cause or the executive voluntarily terminates his or her employment for good reason, the executive is entitled to the following:

a lump sum payment in an amount equal to three times (two times in the casea multiple of Messrs. Hrudicka, Kill and Glandon) the executive’s annual salary;base salary (three times for Mr. Duda and two times for Messrs. Tsoumas, Brotherton and Shetty);
a lump sum payment equal to three times (two times in the casea multiple of Messrs. Hrudicka, Kill and Glandon) the lesser of: (a) the executive’s target bonus amount for the fiscal year in which executive’s employment termination occurs, or (b) the bonus the executive earned in the prior fiscal year;year (three times for Mr. Duda and two times for Messrs. Tsoumas, Brotherton and Shetty); and
continued participation in our welfare benefit plans for three years (twofor Mr. Duda and two years in the case offor Messrs. Hrudicka, KillTsoumas, Brotherton and Glandon)Shetty, or until the executive becomes covered under other welfare benefit plans providing substantially similar benefits.

The following table shows the potential amounts payable to our currently serving named executive officers upon termination or a change of control of Methode. The information shown for Mr. Koman reflects the compensation received in connection with his qualified retirement in September 2016. The amounts shown assume that such termination was effective as of April 28, 201726, 2019 (the last trading day of our 20172019 fiscal year), and reflect the price of our common stock on such date ($44.55)29.33) and reflects awards outstanding and unvested on such date. The table below does not reflect amounts payable to our named executive officers pursuant to plans or arrangements that are available generally to salaried employees, such as payments under the 401(k) Plan, the life insurance plan, the disability insurance plan and the vacation pay policy, payment of accrued base salary and accrued bonuses and, in the case of Mr. Khoury, payments under the Lebanese Labor Laws. In addition, the table does not reflect the distribution of each officer’s account balance in our Deferred Compensation Plan or the delivery of common stock underlying outstanding vested restricted stock units. For purposes of this table, we have assumed that our Compensation Committee has elected to accelerate all awards in each instance in which acceleration is subject to the discretion of our Compensation Committee.

Name
Termination Scenario
(on 4/26/19)
Salary and
Bonus
Severance
($)
Payment of
Annual
Performance-
Based Bonus
($)
Vesting of
RSUs ($)
Vesting of
RSAs ($)(1)
Health and
Welfare
Benefits
($)(2)
Donald W. Duda
Upon Change of Control(3)
 
 
 
759,719
 
 
1,407,840
 
 
5,623,200
 
 
 
Resignation for Good Reason/Termination Without Cause Following Change of Control(4)
 
3,646,653
 
 
 
 
 
 
 
 
68,165
 
Death or Disability
 
 
 
759,719
 
 
1,407,840
 
 
5,623,200
 
 
 
Qualified Retirement
 
 
 
759,719
 
 
1,126,272
 
 
4,498,560
 
 
 
Ronald L.G. Tsoumas
Upon Change of Control(3)
 
 
 
264,000
 
 
258,104
 
 
1,030,920
 
 
 
Resignation for Good Reason/Termination Without Cause Following Change of Control(4)
 
920,698
 
 
 
 
 
 
 
 
29,919
 
Death or Disability
 
 
 
264,000
 
 
258,104
 
 
1,030,920
 
 
 
Qualified Retirement
 
 
 
264,000
 
 
206,483
 
 
824,726
 
 
 

35

Name
Termination Scenario
(on 4/26/19)
Salary and
Bonus
Severance
($)
Payment of
Annual
Performance-
Based Bonus
($)
Vesting of
RSUs ($)
Vesting of
RSAs ($)(1)
Health and
Welfare
Benefits
($)(2)
Joseph E. Khoury
Upon Change of Control(3)
 
 
 
294,756
 
 
703,920
 
 
2,811,600
 
 
 
Resignation for Good Reason/ Termination Without Cause Following Change of Control
 
 
 
 
 
 
 
 
 
 
Death or Disability
 
 
 
294,756
 
 
703,920
 
 
2,811,600
 
 
 
Qualified Retirement
 
 
 
294,756
 
 
563,136
 
 
2,249,280
 
 
 
Michael Brotherton
Upon Change of Control(3)
 
 
 
224,400
 
 
281,568
 
 
1,124,640
 
 
 
Resignation for Good Reason/ Termination Without Cause Following Change of Control(4)
 
1,114,272
 
 
 
 
 
 
 
 
47,758
 
Death or Disability
 
 
 
224,400
 
 
281,568
 
 
1,124,640
 
 
 
Qualified Retirement
 
 
 
224,400
 
 
225,254
 
 
899,712
 
 
 
Anil Shetty
Upon Change of Control(3)
 
 
 
245,520
 
 
281,568
 
 
1,124,640
 
 
 
Resignation for Good Reason/ Termination Without Cause Following Change of Control(4)
 
1,114,968
 
 
 
 
 
 
 
 
44,702
 
Death, Disability
 
 
 
245,520
 
 
281,568
 
 
1,124,640
 
 
 
Qualified Retirement
 
 
 
245,520
 
 
225,254
 
 
899,712
 
 
 
36 

Name

Termination Scenario

(on 4/28/17)

Salary and Bonus Severance

($)

Payment of Annual Performance-Based Bonus
($)

Vesting of Option Awards

($)

Vesting of RSUs ($)Vesting of RSAs ($)(1)

Health and Welfare Benefits

($) (2)

Donald W. DudaUpon Change of Control (3)--716,108100,5335,346,0008,132,400--
 Resignation for Good Reason/Termination Without Cause Following Change of Control (4)4,296,648--------71,021
 Death or Disability--716,108100,5335,346,0008,132,400--
 Qualified Retirement--716,108100,5332,138,4003,363,120--
John R. HrudickaUpon Change of Control (3)--297,000--1,425,6002,151,360--
 Resignation for Good Reason/Termination Without Cause Following Change of Control (4)1,929,462--------71,021
 Death or Disability--297,000--1,425,6002,151,360--
 Qualified Retirement--297,000--570,240547,560--
Joseph E. KhouryUpon Change of Control (3)--240,01230,1602,673,0004,066,200--
 Resignation for Good Reason/ Termination Without Cause Following Change of Control------------
 Death or Disability--240,01230,1602,673,0004,066,200--
 Qualified Retirement--240,01230,1601,069,2001,681,560--
Theodore P. KillUpon Change of Control (3)--210,568--2,673,0004,066,200--
 Resignation for Good Reason/ Termination Without Cause Following Change of Control (4)1,054,576--------15,480
 Death or Disability--210,568--2,673,0004,066,200--
 Qualified Retirement--210,568--1,069,2001,681,560--
Timothy R. GlandonUpon Change of Control (3)----30,160------
 Resignation for Good Reason/ Termination Without Cause Following Change of Control (4)590,000--------47,347
 Death, Disability----30,160------
 Qualified Retirement----30,160------
Douglas A. KomanQualified Retirement--138,30726,894393,255794,047--
        

(1)For purposes of this table, we have assumed that the target performance level will be achieved with respect to the RSAs. Amounts include an amount equal to the cash dividends declared during the period from the date of grant thru April 28, 2017,26, 2019, multiplied by the number of RSAs vestedvested.
(2)Reflects the estimated lump-sum present value of all future premiums which will be paid on behalf of the executive under our health and welfare benefit plans.
(3)Includes amounts payable where the successor company assumed an award and then terminated an executive without cause or the executive resigned with good reason.reason (i.e., “double trigger”).
(4)These amounts are in addition to amounts payable under the preceding row “Upon Change of Control.”
37 

CEO Pay Ratio

As required by Section 953(b) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(u) of SEC Regulation S-K, we are providing the following information about the ratio of the median annual total compensation of our employees to the annual total compensation of our Chief Executive Officer, Donald W. Duda.

For fiscal 2019, the median of the annual total compensation of all of our employees (other than Mr. Duda) was $10,571 and Mr. Duda’s annual total compensation was $1,389,578, as reported in the Summary Compensation Table. Based on this information, the ratio of the annual total compensation of Mr. Duda to the median of the annual total compensation of all of our employees (other than Mr. Duda) was 131 to 1. In our view, this ratio is a reasonable estimate calculated in a manner consistent with Item 402(u) of SEC Regulation S-K using the data and assumptions summarized below. Using Mr. Duda’s adjusted annual total compensation of $3,416,378 as reported in the Alternative Summary Compensation Table increases the ratio to 323 to 1.

To identify the median of the annual total compensation of all of our employees, we first determined our employee population as of February 1, 2019. As a global manufacturer, we have employees in the United States, Mexico, Malta, Egypt, China, Canada, India, Belgium, Lebanon, the United Kingdom, Switzerland, Singapore and Hong Kong. As of February 1, 2019, we had 6,187 employees worldwide.

36

For purposes of identifying the median employee from our employee population, we considered annual base salary as of February 1, 2019, plus overtime, allowances and short-term incentive compensation for the trailing twelve months, each as reported in our payroll records and adjusted to US dollars based on foreign currency exchange rates in effect as of March 12, 2019. We did not make any cost-of-living adjustments to the pay of employees living in different jurisdictions than our CEO, but we did include certain adjustments for the annualization of pay for employees who were employed for only part of the period.

Using the above methodology, we determined that our median employee was a full-time stamping technician located in Mexico. We then calculated the elements of such employee’s compensation for fiscal 2019 in accordance with the requirements of Item 402(c)(2)(x) of SEC Regulation S-K, resulting in annual total compensation in the amount of $10,571.

The pay ratio and median annual total compensation disclosed above reflect that the bulk of our employees are located in countries that have much lower prevailing wages than the United States. The assumptions used in the calculation of our estimated pay ratio are specific to our company and our employee population. As such, our pay ratio may not be comparable to the pay ratios of other companies, including companies in our compensation peer group.

37

OTHER INFORMATION

Delinquent Section 16(a) Beneficial Ownership Reporting ComplianceReports

Under the securities laws, our directors and executive officers are required to report their initial ownership of our common stock and any subsequent changes in that ownership to the SEC. Specific due dates for these reports have been established and we are required to disclose in this proxy statement if a director or executive officer filed a late report. During fiscal 2017,2019, all such reports were timely filed. In making these disclosures, we have relied solely on written representations of our directors and executive officers and copies of the reports filed with the SEC.

Availability of Annual Report

Methode is providing its Annual Report to shareholders who receive this proxy statement. Methode will provide copies of the Annual Report to brokers, dealers, banks, voting trustees and their nominees for the benefit of their beneficial owners of record. Additional copies of this proxy statement, the Annual Report and Methode’s Annual Report on Form 10-K for the fiscal year ended April 29, 201727, 2019 are available, without charge, upon written request to Methode Electronics, Inc., 74018750 West WilsonBryn Mawr Avenue, Suite 1000, Chicago, Illinois 60706,60631, Attention: Chief Financial Officer. You may also review Methode’s SEC filings by visiting our website atwww.methode.comwww.methode.com..

Shareholder Proposals and Director Nominations

If you wish to submit a shareholder proposal for inclusion in our proxy materials for our 2018 Annual Meeting,2020 annual meeting, our Corporate Secretary must receive your proposal no later than April 3, 2018.March 28, 2020. Your proposal must be in writing and must comply with the proxy rules of the SEC.

Our advance notice by-law provisions require that any shareholder proposal or director nomination to be presented from the floor of our 2018 Annual Meeting2020 annual meeting must be received by our Corporate Secretary not later than the 60th60th day nor earlier than the 90th90th day prior to September 14, 201812, 2020 (the first anniversary of the preceding year’s annual meeting). If the date of our 2018 Annual Meeting2020 annual meeting is more than 30 days before or more than 60 days after September 14, 2018,12, 2020, shareholder proposals must be delivered no earlier than the 90th90th day prior to such annual meeting date and not later than the later of the 60th60th day prior to such annual meeting date or the 10th10th day following our public announcement of the meeting date for such annual meeting. Any shareholder proposal must be, under law, an appropriate subject for shareholder action in order to be brought before the meeting. In addition, in order to present a shareholder proposal or nominate a director at our 2018 Annual Meeting,2020 annual meeting, the shareholder must satisfy certain other requirements set forth in our Amended and Restated By-Laws. Shareholder proposals and director nominations should be directed to the Corporate Secretary of Methode Electronics, Inc. at 74018750 West WilsonBryn Mawr Avenue, Suite 1000, Chicago, Illinois 60706.60631.

Other Matters

Neither our Board of Directors nor management knows of any other business that will be presented at the annual meeting. Should any other business properly come before the annual meeting, the persons named in the proxy will vote on such matters in accordance with their best judgment.

By Order of the Board of Directors,

Walter J. Aspatore
Chairman

Chicago, Illinois

August 1, 2017

38 

 (METHODE ELECTRONICS)

METHODE ELECTRONICS, INC.
7401 WEST WILSON AVENUE
CHICAGO, IL 60706-4548

VOTE BY INTERNET - www.proxyvote.com

Use the Internet to transmit your voting instructions for electronic delivery of information up until 11:59 P.M. Eastern Time the day before the annual meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.

ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS

Methode Electronics, Inc. encourages you to take advantage of convenient ways to vote these shares. If voting by proxy, you may grant a proxy by mail, or choose one of the two methods described below. Your telephone or Internet proxy authorizes the named proxies to vote these shares in the same manner as if you marked, signed, and returned your proxy card. To grant your proxy by telephone or Internet, read the annual meeting proxy statement and then follow these easy steps:

VOTE BY PHONE - 1-800-690-6903

Use any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. Eastern Time the day before the annual meeting date. Have your proxy card in hand when you call and then follow the simple instructions the vote voice provides you.

VOTE BY MAIL

Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.

TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:

KEEP THIS PORTION FOR YOUR RECORDS
DETACH AND RETURN THIS PORTION ONLY
THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.
The Board of Directors recommends you vote FOR the following:
1.Election of Directors
Nominees
For  Against  Abstain
1a.Walter J. AspatoreThe Board of Directors recommends you vote FOR proposals 2 and 3.ForAgainstAbstain
1b.Darren M. Dawson2The ratification of the Audit Committee's selection of Ernst & Young LLP to serve as our independent registered public accounting firm for the fiscal year ending April 28, 2018.
1c.Donald W. Duda
1d.Martha Goldberg Aronson
1e.Isabelle C. Goossen3The advisory approval of Methode's named executive officer compensation.
1f.Christopher J. Hornung ☐  ☐ 
1g. Paul G. SheltonThe Board of Directors recommends you vote 1 YEAR on the following proposal:1 year2 years3 yearsAbstain
1h.Lawrence B. Skatoff
4To recommend, by non-binding vote, the frequency of advisory votes on named executive officer compensation. ☐☐  ☐☐ 
NOTE:Such other business as may properly come before the meeting or any adjournment thereof.
Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer.
Signature [PLEASE SIGN WITHIN BOX]DateSignature (Joint Owners)Date

0000341962_1     R1.0.1.15

Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: The Notice & Proxy Statement and Annual Report are available atwww.proxyvote.com

METHODE ELECTRONICS, INC.
This proxy is solicited by the Board of Directors,
Annual Meeting of the Shareholders
The undersigned hereby appoints
Walter J. Aspatore Donald W. Duda and John R. Hrudicka, and each of them, with full power of substitution, as proxies to vote all shares of Methode Electronics, Inc. common stock which the undersigned is entitled to vote at the Annual Meeting of Methode Electronics, Inc. to be held on Thursday, September 14, 2017 at 11:00 a.m., Central Daylight Time, at Methode's corporate offices at 7401 West Wilson Avenue, Chicago, Illinois 60706, and at any adjournment or postponement thereof.
This proxy when properly signed will be voted in the manner directed herein by the undersigned shareholder. IF NO DIRECTION IS PROVIDED, THIS PROXY WILL BE VOTED AS RECOMMENDED BY THE BOARD OF DIRECTORS. If other business is presented at the Annual Meeting, this proxy shall be voted in accordance with the best judgment of the persons named as proxies above.
Continued and to be signed on reverse side
Chairman

0000341962_2     R1.0.1.15Chicago, Illinois
July 26, 2019

38